Adrian89 personal page - To The Moon

Adrian89

Adrian89

No personal profile

17Follow

0Followers

0Topic

0Badge

2021-08-17

??

Sorry, the original content has been removed

2021-07-02

[Surprised]

The Stock Market Had a Great First Half. 3 Things That Could Cause it to Crash.

2021-06-21

[Cry]

Nike, FedEx, Johnson & Johnson, Darden, and Other Stocks for Investors to Watch This Week

2021-08-04

$Novavax(NVAX)$to the moon!

2021-06-24

[Smile]

Temasek-backed online pharmacy seeks funds at US$4b valuation: sources

2021-03-12

$Freeport-McMoRan(FCX)$keep going!

2021-07-09

$Match(MTCH)$yay!

2021-06-24

[Miser]

IPO Watch: Bright Health, Monte Rosa, Confluent to Start Trading Today

2021-06-21

Just a passing storm!

Dow jumps more than 200 points, rebounds from its worst week since October

2021-06-21

$PayPal(PYPL)$To greater heights!

2021-06-18

$Match(MTCH)$up!

2021-05-24

$IDEXX Laboratories(IDXX)$=)

2021-07-02

[Smile]

Look back to the first half of the year: U.S. stock indexs hit record high, these stocks are winner

2021-06-25

Awesome!

Eli Lilly Surges After Getting Breakthrough Therapy Designation From FDA, Analyst Raises PT and Sees Approval Chance at 90%, Biogen Plunges

2021-06-25

[Surprised]

Nike forecast for online sales boom, post-lockdown demand drives shares up 13%

2021-06-24

$Visa(V)$[Miser]

2021-06-23

Good day for S&P

2021-06-23

$Moderna, Inc.(MRNA)$[Surprised] [Surprised] [Surprised]

2021-06-21

To greater heights! [Miser]

2021-06-16

$Roblox Corporation(RBLX)$=(=(=(

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3575669786186618","uuid":"3575669786186618","gmtCreate":1612576424860,"gmtModify":1615601700850,"name":"Adrian89","pinyin":"adrian89","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":17,"tweetSize":22,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":7,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.03","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.34%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.52%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":833136071,"gmtCreate":1629209536393,"gmtModify":1676529967325,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"??&nbsp;","listText":"??&nbsp;","text":"??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/833136071","repostId":"1115558959","repostType":4,"repost":{"id":"1115558959","kind":"news","pubTimestamp":1629192455,"share":"https://ttm.financial/m/news/1115558959?lang=&edition=fundamental","pubTime":"2021-08-17 17:27","market":"us","language":"en","title":"This Is What Hedge Funds Bought And Sold In Q2: Complete 13F Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=1115558959","media":"zerohedge","summary":"For once, the \"smart money\" was not caught off guard by the resurgent covid pandemic, and as a barra","content":"<p>For once, the \"smart money\" was not caught off guard by the resurgent covid pandemic, and as a barrage of 13F filings published today showed, during the second quarter hedge funds loaded up on companies that would benefit from a new wave of the pandemic even before the delta variant began to rapidly spread throughout the U.S.</p>\n<p>As Bloomberg summarizes, Chase Coleman’s Tiger Global Management and&nbsp;Philippe Laffont’s Coatue Management both increased their stakes in food delivery service&nbsp;DoorDash in the second quarter. Coatue also added to its bet on vaccine maker&nbsp;Moderna, while&nbsp;Stephen Mandel’s Lone Pine Capital took a new stake in the biotech company worth more than $900 million. These purchases were a reversal from the first quarter, when many hedge funds cut positions in<i>Work From Home</i>companies like&nbsp;Peloton and&nbsp;Zoom as vaccinations began to ramp up in the U.S. That, in turn, fueled wagers on companies that had been hardest-hit by travel restrictions and remote work.</p>\n<p>Tiger and Coatue also increased their stakes in Zoom in the three months through June, their 13F filings revealed. The two funds, along with D1 Capital Partners, were among those that added to positions in Peloton, while Viking Global Investors made a new bet on the exercise equipment company.</p>\n<p>13F filings also showed that funds including Soros Fund Management and Temasek snapped up shares of fintech companies. Marqeta was a top new buy for Soros, while Temasek disclosed new positions in SoFi Technologies, Flywire and Payoneer Global. Marqeta and SoFi tumbled last week after reporting disappointing second-quarter results. Temasek also snapped up shares in two new BlackRock carbon transition ETFs (LCTU and LCTD), while Soros took a new position in electric-vehicle producer Proterra, as clean energy continues to be a prominent trend among investors.</p>\n<p>Coatue, Viking and&nbsp;Gabe Plotkin’s Melvin Capital Management also added new positions in Beijing-based JD.com Inc. in the quarter, a move that would prove to be rather unfortunate as shares of the giant online vendor have slumped 16% since June 30. Chinese shares have tumbled since June as Beijing banned for-profit tutoring companies and ordered more than two dozen tech firms to carry out internal inspections and address issues such as data security.</p>\n<p>Some, such as Soros were either lucky or good in cutting their exposure to Chinese ADRs in the second quarter, ahead of the furious selloff. Soros Fund Management exited many of its investments in Chinese ADRs including Baidu, Vipshop Holdings, Tencent Music Entertainment Group and IQiyi, positions it snapped up during the collapse of Archegos Capital Management in March and April, as noted previously.</p>\n<p>Other funds also dumped China-based companies with listings in the U.S. D1 Capital sold its 25-million-share stake in New Oriental Education &amp; Technology Group, while Soroban Capital Partners exited its 2.06-million-share stake in Alibaba. Soroban’s largest new positions favored tech, with the top three additions being Facebook, Twitter and Netflix.</p>\n<p>Some other notable 13F findings:</p>\n<ul>\n <li>Michael Burry, of “The Big Short” fame, owned puts on&nbsp;Cathie Wood’s ARK Innovation ETF and increased its Tesla puts (more here).</li>\n <li>Warren Buffett’s Berkshire Hathaway added to just three positions in the quarter and trimmed its holdings in several companies, including a full exit of controversial Alzheimer’s drug developer Biogen. As firstnoted earlier, Berkshire’s only new position in the quarter, 1.55 million shares of Organon was the result of a spinoff of the women’s health pharmaceutical company from Berkshire holding Merck. Its most significant addition was a 21% increase in its position in grocer Kroger. Besides Biogen, exits included Liberty Global’s Class A shares and Axalta Coating Systems, while Berkshire trimmed positions in Marsh &amp; McLennan, Abbvie, General Motors and Bristol-Myers Squibb.</li>\n <li>Seth Klarman’s long-standing investment in&nbsp;Rupert Murdoch’s media empire finally came to an end during the second quarter. Baupost Group sold its entire Fox Corp. stake, including 7.6 million Class A shares and 5.7 million Class B shares with a combined market value of $446 million at the end of March.</li>\n <li>Carl Icahn, who runs a concentrated portfolio with just 17 reportable investments, sold all of his 9.59 million shares of Tenneco in the quarter. He also has a new undisclosed position in an unnamed stock -- an unusual step that requires a separate filing with the Securities and Exchange Commission.</li>\n <li>Dan Loeb's Third Point added SentinelOne Class A to its investments and exited IAA in the second quarter. The fund also added to its holdings in Intel, boosting its stake to 14 million shares from 1 million, while decreasing its stake in Charter Communications Class A. Upstart Holdings was Third Point's biggest holding, representing 9.8% of disclosed assets</li>\n <li>Elliott Investment Management’s largest purchases of the quarter included a 3-million-share buy of Twitter. The increase in shares comes despite Elliott partner Jesse Cohn’s departure from Twitter’s board on June 9. He originally joined the board as part of a partnership Twitter entered with Elliott and Sliver Lake on March 9, 2020.</li>\n <li>Singapore state-owned investment fund Temasek Holdings’s largest new purchase in the quarter was a 4.84-million-share position in Airbnb. Airbnb reported strong second-quarter earnings last week that were offset by tepid guidance, according to analysts. Temasek also disclosed new positions in SoFi Technologies, Flywire and Payoneer Global.</li>\n</ul>\n<p><i>Here are some other moves made by prominent funds tracked by Bloomberg:</i></p>\n<p>APPALOOSA</p>\n<ul>\n <li>Top new buys: UBER, PHM, BODY, TCVA</li>\n <li>Top exits: CRM, ADBE, DIS, PYPL, IQ, DISCA, BIDU, SHOP</li>\n <li>Boosted stakes in: MOS, FCX</li>\n <li>Cut stakes in: PCG, MU, TMUS, AMZN, CHK, BABA, FB, GOOG, HCA, XLE</li>\n</ul>\n<p>BAUPOST GROUP</p>\n<ul>\n <li>Top new buys: SJR, RTPY, 1865300D</li>\n <li>Top exits: FOXA, FOX, PEAK, FNF, RTP, HIPO</li>\n <li>Boosted stakes in: FB, MU, QRVO, TBPH</li>\n <li>Cut stakes in: INTC, WLTW, EBAY, PSTH, SSNC, ADV, AJAX, NXST, DBRG, LBTYK</li>\n</ul>\n<p>BERKSHIRE HATHAWAY</p>\n<ul>\n <li>Top exits: AXTA, BIIB, LBTYA</li>\n <li>Boosted stakes in: KR, RH, AON</li>\n <li>Cut stakes in: GM, BMY, ABBV, LBTYK, CVX, MMC, USB</li>\n</ul>\n<p>CORVEX MANAGEMENT</p>\n<ul>\n <li>Top new buys: CRM, ZNGA, BOAC, ROVR, TWCT, LGV</li>\n <li>Top exits: FISV, EXPE, GLD, FE, GPN, RADI, ORGN, TALK, ELMS, NFLX</li>\n <li>Boosted stakes in: BLMN, AMZN, GOOGL, DIS, MSFT, CCEP, ATUS, EXC, DOMA, FB</li>\n <li>Cut stakes in: ATVI, TMUS, AJAX, CFAC</li>\n</ul>\n<p>D1 CAPITAL PARTNERS</p>\n<ul>\n <li>Top new buys: PCOR, FTCH, PODD, ALKT, CMG, DLO, DECK, STNE, CRWD, FTV</li>\n <li>Top exits: HLT, NFLX, EDU, BAX, NKE, PPD, LVS, FIS, BX, BMBL</li>\n <li>Boosted stakes in: AMZN, EXPE, CVNA, PTON, BBWI, JD, RH, BLL, BKNG, DIS</li>\n <li>Cut stakes in: MSFT, TMUS, FB, COUP, DHR, DDOG</li>\n</ul>\n<p>DUQUESNE FAMILY OFFICE</p>\n<ul>\n <li>Top new buys: NFLX, ABNB, MRNA, SMAR, GM, COUP, MAR, FTCH, CF, RBLX</li>\n <li>Top exits: C, GOLD, MELI, UBER, TSM, LIN, RUN, JPM, AA, ASHR</li>\n <li>Boosted stakes in: GOOGL, AMZN, CVNA, FB, KBR, MA, V, SBUX, EXPE, OPCH</li>\n <li>Cut stakes in: MSFT, SE, ON, BLDR, PLTR, FLEX, TMUS, SNOW, TECK, FCX</li>\n</ul>\n<p>ELLIOTT INVESTMENT MANAGEMENT</p>\n<ul>\n <li>Top new buys: DUK, DBX, HRB</li>\n <li>Top exits: DISCK, CYH, FB</li>\n <li>Boosted stakes in: TWTR, ETWO, PINS</li>\n <li>Cut stakes in: SNAP, HWM</li>\n</ul>\n<p>GLENVIEW CAPITAL MANAGEMENT</p>\n<ul>\n <li>Top new buys: CNC, AMZN, BABA, CCCS, UBER, AMGN, CHNG, OUST, BOWX, LSAQ</li>\n <li>Top exits: NUAN, LH, MSFT, CAR, LYFT, MAR, PPD, NBSE</li>\n <li>Boosted stakes in: GPN, CCEP, APTV, WBA, DD, CTVA, DVA, NSC, HOLX, ESI</li>\n <li>Cut stakes in: CI, TAK, HCA, MCK, DXC, FB, ANTM, BSX, BAX, FISV</li>\n</ul>\n<p>GREENLIGHT CAPITAL</p>\n<ul>\n <li>Top new buys: SPY, PLBY, GPK, NWS, SRNG, EXPE, DMYI, LIVN, UWMC, PANA</li>\n <li>Top exits: ADT, ALIT, TALK, SEAH</li>\n <li>Boosted stakes in: TECK, GPRO, ODP, CC, CPRI, JOBY, SATS, ASTS, FUBO, REZI</li>\n <li>Cut stakes in: DNMR, APG, KPLT, CNX, XOG, CNXC, JACK, SNX, NUVB, CEIX</li>\n</ul>\n<p>ICAHN</p>\n<ul>\n <li>Top exits: HLF, TEN</li>\n <li>Boosted stakes in: IEP, XRX</li>\n <li>Cut stakes in: OXY, DK, WBT</li>\n</ul>\n<p>JANA PARTNERS</p>\n<ul>\n <li>Top new buys: CSOD</li>\n <li>Boosted stakes in: CONE, VG, SPY, EHC</li>\n <li>Cut stakes in: LH, CAG, THS</li>\n</ul>\n<p>LANSDOWNE</p>\n<ul>\n <li>Top new buys: ILMN, WMG, NVT</li>\n <li>Top exits: ED, DAR, AES, REGI, CDE, PAAS, USO</li>\n <li>Boosted stakes in: ETN, FCX, CARR, AER, DAL, IEUR, BLBD, VMC, RBLX, UVXY</li>\n <li>Cut stakes in: AMAT, TSM, LRCX, MU, RYAAY, GE, ENIA, EGO, ADI, BKNG</li>\n</ul>\n<p>MAVERICK CAPITAL</p>\n<ul>\n <li>Top new buys: CNC, JLL, CANO, FTCH, GPN, BHG, CMAX, ADSK, SE, JWSM</li>\n <li>Top exits: FIS, PLD, ELAN, LVS, SPFR, MAC, DASH, TJX, ZBRA, HPQ</li>\n <li>Boosted stakes in: CVNA, ASO, SNOW, V, BABA, EXPE, TMUS, CCK, XP, ATRA</li>\n <li>Cut stakes in: SEER, AMAT, ALNY, LRCX, AON, AMZN, LPLA, SUM, TGTX, GOOG</li>\n</ul>\n<p>MELVIN CAPITAL MANAGEMENT</p>\n<ul>\n <li>Top new buys: JD, DASH, PYPL, DPZ, MSFT, TGT, VMEO, SE, SHOP, DDOG</li>\n <li>Top exits: NFLX, NUAN, PINS, AAP, NKE, MU, SIG, TPX, TPR, WYNN</li>\n <li>Boosted stakes in: AMZN, ATVI, ALGN, LYV, LH, EXPE, SEAS, SNOW, PVH, TXRH</li>\n <li>Cut stakes in: MA, FB, BBWI, GOOGL, SBUX, UBER, FICO, NTES, HLT, NOW</li>\n</ul>\n<p>OMEGA ADVISORS</p>\n<ul>\n <li>Top new buys: LAD, BHC, VOO, PFSI, EFA, IVW, COG, SCHO, IEUR, EWJ</li>\n <li>Top exits: MGY, IFF, CMCSA</li>\n <li>Boosted stakes in: FOA, WSC, VRT, NRG, PXD, ABR, ASH, ASPU, BABA, FLMN</li>\n <li>Cut stakes in: FOE, NAVI, OCN, TRN, BBDC, FCRD, SRGA, FB, SNR</li>\n</ul>\n<p>PERSHING SQUARE</p>\n<ul>\n <li>Boosted stakes in: DPZ</li>\n <li>Cut stakes in: LOW, QSR, HLT, A</li>\n</ul>\n<p>SOROBAN CAPITAL</p>\n<ul>\n <li>Top new buys: FB, TWTR, NFLX, WAB, KAHC, LGV, BKI, PLNT, MSDA, TIOA</li>\n <li>Top exits: BABA, CMCSA, DPZ, RTX, GRA, GWRE, ALIT, SFTW, SPFR</li>\n <li>Boosted stakes in: LOW, CSX, ADI, UNP, FIS, VYGG, BTNB</li>\n <li>Cut stakes in: ATUS, SPGI, PAYO, KVSB, ME, SUNL, BGRY, GNAC, DOMA, NSH</li>\n</ul>\n<p>SOROS FUND MANAGEMENT</p>\n<ul>\n <li>Top new buys: FIGS, INFO, PTRA, MQ, PPD, VER, NUAN, MGLN, INDI, ACN</li>\n <li>Top exits: BIDU, DEN, VIPS, TME, IQ, DISCK, XLE, MU, ASHR, WAL</li>\n <li>Boosted stakes in: AMZN, MXIM, ELAN, GOOGL, CLVT, DIS, OPEN, W, CRM, SYF</li>\n <li>Cut stakes in: LQD, QS, VICI, UPST, TXN, LVS, ADI, NXPI, DHI, LPLA</li>\n</ul>\n<p>STARBOARD</p>\n<ul>\n <li>Top new buys: PZZA, WPCB, LEGA, KAHC, SLAM, FRXB, ATMR, ROSS, MACC, ACAH</li>\n <li>Boosted stakes in: CERN, BOX, IWM, IWR, TWCT, KVSC, DGNU, PRPB, LNFA, ON</li>\n <li>Cut stakes in: CTVA, IWN, ACM, MAAC, SCOR, NLOK, MMSI, ELAN, CVLT</li>\n</ul>\n<p>TEMASEK HOLDINGS</p>\n<ul>\n <li>Top new buys: ABNB, INTA, FLYW, PAYO, KRE, STEM, LCTU, INTC, SOFI, COPX</li>\n <li>Top exits: XLF, ADBE, INDA, EWZ, ACIU, PCVX</li>\n <li>Boosted stakes in: BILL, BEAM, TMO, DELL, EWY, IBN, IAU, CRM, SNOW, AFRM</li>\n <li>Cut stakes in: WISH, IWM, BABA, MSFT, XLB, CTVA, DASH, RBLX</li>\n</ul>\n<p>THIRD POINT</p>\n<ul>\n <li>Top new buys: S, SOFI, EDR, ZBH, PTON, RTPY, JWSM, ASZ, IACC, AUS</li>\n <li>Top exits: IAA, RACE, KMX, Z, SHOP, CVNA, ETRN, NYT, WISH, RKT</li>\n <li>Boosted stakes in: INTC, AMZN, DELL, CANO, EL, UBER, SU, RH, DD, AES</li>\n <li>Cut stakes in: CHTR, PCG, JD, IQV, DIS, RADI, APTV, BOAC, MTTR, TEL</li>\n</ul>\n<p>TIGER GLOBAL</p>\n<ul>\n <li>Top new buys: PCOR, PATH, COIN, DV, BHG, DLO, APP, S, GRUB, KPLT</li>\n <li>Top exits: ASO</li>\n <li>Boosted stakes in: DASH, DOCU, ZM, SHOP, SE, SNOW, CVNA, PTON, YSG, RNG</li>\n <li>Cut stakes in: CRM, TAL, JD, EDU, RBLX, GDS, UBER, DESP, BABA, RDFN</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Is What Hedge Funds Bought And Sold In Q2: Complete 13F Summary</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Is What Hedge Funds Bought And Sold In Q2: Complete 13F Summary\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-17 17:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/markets/what-hedge-funds-bought-and-sold-q2-complete-13f-summary><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For once, the \"smart money\" was not caught off guard by the resurgent covid pandemic, and as a barrage of 13F filings published today showed, during the second quarter hedge funds loaded up on ...</p>\n\n<a href=\"https://www.zerohedge.com/markets/what-hedge-funds-bought-and-sold-q2-complete-13f-summary\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"source_url":"https://www.zerohedge.com/markets/what-hedge-funds-bought-and-sold-q2-complete-13f-summary","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115558959","content_text":"For once, the \"smart money\" was not caught off guard by the resurgent covid pandemic, and as a barrage of 13F filings published today showed, during the second quarter hedge funds loaded up on companies that would benefit from a new wave of the pandemic even before the delta variant began to rapidly spread throughout the U.S.\nAs Bloomberg summarizes, Chase Coleman’s Tiger Global Management and Philippe Laffont’s Coatue Management both increased their stakes in food delivery service DoorDash in the second quarter. Coatue also added to its bet on vaccine maker Moderna, while Stephen Mandel’s Lone Pine Capital took a new stake in the biotech company worth more than $900 million. These purchases were a reversal from the first quarter, when many hedge funds cut positions inWork From Homecompanies like Peloton and Zoom as vaccinations began to ramp up in the U.S. That, in turn, fueled wagers on companies that had been hardest-hit by travel restrictions and remote work.\nTiger and Coatue also increased their stakes in Zoom in the three months through June, their 13F filings revealed. The two funds, along with D1 Capital Partners, were among those that added to positions in Peloton, while Viking Global Investors made a new bet on the exercise equipment company.\n13F filings also showed that funds including Soros Fund Management and Temasek snapped up shares of fintech companies. Marqeta was a top new buy for Soros, while Temasek disclosed new positions in SoFi Technologies, Flywire and Payoneer Global. Marqeta and SoFi tumbled last week after reporting disappointing second-quarter results. Temasek also snapped up shares in two new BlackRock carbon transition ETFs (LCTU and LCTD), while Soros took a new position in electric-vehicle producer Proterra, as clean energy continues to be a prominent trend among investors.\nCoatue, Viking and Gabe Plotkin’s Melvin Capital Management also added new positions in Beijing-based JD.com Inc. in the quarter, a move that would prove to be rather unfortunate as shares of the giant online vendor have slumped 16% since June 30. Chinese shares have tumbled since June as Beijing banned for-profit tutoring companies and ordered more than two dozen tech firms to carry out internal inspections and address issues such as data security.\nSome, such as Soros were either lucky or good in cutting their exposure to Chinese ADRs in the second quarter, ahead of the furious selloff. Soros Fund Management exited many of its investments in Chinese ADRs including Baidu, Vipshop Holdings, Tencent Music Entertainment Group and IQiyi, positions it snapped up during the collapse of Archegos Capital Management in March and April, as noted previously.\nOther funds also dumped China-based companies with listings in the U.S. D1 Capital sold its 25-million-share stake in New Oriental Education & Technology Group, while Soroban Capital Partners exited its 2.06-million-share stake in Alibaba. Soroban’s largest new positions favored tech, with the top three additions being Facebook, Twitter and Netflix.\nSome other notable 13F findings:\n\nMichael Burry, of “The Big Short” fame, owned puts on Cathie Wood’s ARK Innovation ETF and increased its Tesla puts (more here).\nWarren Buffett’s Berkshire Hathaway added to just three positions in the quarter and trimmed its holdings in several companies, including a full exit of controversial Alzheimer’s drug developer Biogen. As firstnoted earlier, Berkshire’s only new position in the quarter, 1.55 million shares of Organon was the result of a spinoff of the women’s health pharmaceutical company from Berkshire holding Merck. Its most significant addition was a 21% increase in its position in grocer Kroger. Besides Biogen, exits included Liberty Global’s Class A shares and Axalta Coating Systems, while Berkshire trimmed positions in Marsh & McLennan, Abbvie, General Motors and Bristol-Myers Squibb.\nSeth Klarman’s long-standing investment in Rupert Murdoch’s media empire finally came to an end during the second quarter. Baupost Group sold its entire Fox Corp. stake, including 7.6 million Class A shares and 5.7 million Class B shares with a combined market value of $446 million at the end of March.\nCarl Icahn, who runs a concentrated portfolio with just 17 reportable investments, sold all of his 9.59 million shares of Tenneco in the quarter. He also has a new undisclosed position in an unnamed stock -- an unusual step that requires a separate filing with the Securities and Exchange Commission.\nDan Loeb's Third Point added SentinelOne Class A to its investments and exited IAA in the second quarter. The fund also added to its holdings in Intel, boosting its stake to 14 million shares from 1 million, while decreasing its stake in Charter Communications Class A. Upstart Holdings was Third Point's biggest holding, representing 9.8% of disclosed assets\nElliott Investment Management’s largest purchases of the quarter included a 3-million-share buy of Twitter. The increase in shares comes despite Elliott partner Jesse Cohn’s departure from Twitter’s board on June 9. He originally joined the board as part of a partnership Twitter entered with Elliott and Sliver Lake on March 9, 2020.\nSingapore state-owned investment fund Temasek Holdings’s largest new purchase in the quarter was a 4.84-million-share position in Airbnb. Airbnb reported strong second-quarter earnings last week that were offset by tepid guidance, according to analysts. Temasek also disclosed new positions in SoFi Technologies, Flywire and Payoneer Global.\n\nHere are some other moves made by prominent funds tracked by Bloomberg:\nAPPALOOSA\n\nTop new buys: UBER, PHM, BODY, TCVA\nTop exits: CRM, ADBE, DIS, PYPL, IQ, DISCA, BIDU, SHOP\nBoosted stakes in: MOS, FCX\nCut stakes in: PCG, MU, TMUS, AMZN, CHK, BABA, FB, GOOG, HCA, XLE\n\nBAUPOST GROUP\n\nTop new buys: SJR, RTPY, 1865300D\nTop exits: FOXA, FOX, PEAK, FNF, RTP, HIPO\nBoosted stakes in: FB, MU, QRVO, TBPH\nCut stakes in: INTC, WLTW, EBAY, PSTH, SSNC, ADV, AJAX, NXST, DBRG, LBTYK\n\nBERKSHIRE HATHAWAY\n\nTop exits: AXTA, BIIB, LBTYA\nBoosted stakes in: KR, RH, AON\nCut stakes in: GM, BMY, ABBV, LBTYK, CVX, MMC, USB\n\nCORVEX MANAGEMENT\n\nTop new buys: CRM, ZNGA, BOAC, ROVR, TWCT, LGV\nTop exits: FISV, EXPE, GLD, FE, GPN, RADI, ORGN, TALK, ELMS, NFLX\nBoosted stakes in: BLMN, AMZN, GOOGL, DIS, MSFT, CCEP, ATUS, EXC, DOMA, FB\nCut stakes in: ATVI, TMUS, AJAX, CFAC\n\nD1 CAPITAL PARTNERS\n\nTop new buys: PCOR, FTCH, PODD, ALKT, CMG, DLO, DECK, STNE, CRWD, FTV\nTop exits: HLT, NFLX, EDU, BAX, NKE, PPD, LVS, FIS, BX, BMBL\nBoosted stakes in: AMZN, EXPE, CVNA, PTON, BBWI, JD, RH, BLL, BKNG, DIS\nCut stakes in: MSFT, TMUS, FB, COUP, DHR, DDOG\n\nDUQUESNE FAMILY OFFICE\n\nTop new buys: NFLX, ABNB, MRNA, SMAR, GM, COUP, MAR, FTCH, CF, RBLX\nTop exits: C, GOLD, MELI, UBER, TSM, LIN, RUN, JPM, AA, ASHR\nBoosted stakes in: GOOGL, AMZN, CVNA, FB, KBR, MA, V, SBUX, EXPE, OPCH\nCut stakes in: MSFT, SE, ON, BLDR, PLTR, FLEX, TMUS, SNOW, TECK, FCX\n\nELLIOTT INVESTMENT MANAGEMENT\n\nTop new buys: DUK, DBX, HRB\nTop exits: DISCK, CYH, FB\nBoosted stakes in: TWTR, ETWO, PINS\nCut stakes in: SNAP, HWM\n\nGLENVIEW CAPITAL MANAGEMENT\n\nTop new buys: CNC, AMZN, BABA, CCCS, UBER, AMGN, CHNG, OUST, BOWX, LSAQ\nTop exits: NUAN, LH, MSFT, CAR, LYFT, MAR, PPD, NBSE\nBoosted stakes in: GPN, CCEP, APTV, WBA, DD, CTVA, DVA, NSC, HOLX, ESI\nCut stakes in: CI, TAK, HCA, MCK, DXC, FB, ANTM, BSX, BAX, FISV\n\nGREENLIGHT CAPITAL\n\nTop new buys: SPY, PLBY, GPK, NWS, SRNG, EXPE, DMYI, LIVN, UWMC, PANA\nTop exits: ADT, ALIT, TALK, SEAH\nBoosted stakes in: TECK, GPRO, ODP, CC, CPRI, JOBY, SATS, ASTS, FUBO, REZI\nCut stakes in: DNMR, APG, KPLT, CNX, XOG, CNXC, JACK, SNX, NUVB, CEIX\n\nICAHN\n\nTop exits: HLF, TEN\nBoosted stakes in: IEP, XRX\nCut stakes in: OXY, DK, WBT\n\nJANA PARTNERS\n\nTop new buys: CSOD\nBoosted stakes in: CONE, VG, SPY, EHC\nCut stakes in: LH, CAG, THS\n\nLANSDOWNE\n\nTop new buys: ILMN, WMG, NVT\nTop exits: ED, DAR, AES, REGI, CDE, PAAS, USO\nBoosted stakes in: ETN, FCX, CARR, AER, DAL, IEUR, BLBD, VMC, RBLX, UVXY\nCut stakes in: AMAT, TSM, LRCX, MU, RYAAY, GE, ENIA, EGO, ADI, BKNG\n\nMAVERICK CAPITAL\n\nTop new buys: CNC, JLL, CANO, FTCH, GPN, BHG, CMAX, ADSK, SE, JWSM\nTop exits: FIS, PLD, ELAN, LVS, SPFR, MAC, DASH, TJX, ZBRA, HPQ\nBoosted stakes in: CVNA, ASO, SNOW, V, BABA, EXPE, TMUS, CCK, XP, ATRA\nCut stakes in: SEER, AMAT, ALNY, LRCX, AON, AMZN, LPLA, SUM, TGTX, GOOG\n\nMELVIN CAPITAL MANAGEMENT\n\nTop new buys: JD, DASH, PYPL, DPZ, MSFT, TGT, VMEO, SE, SHOP, DDOG\nTop exits: NFLX, NUAN, PINS, AAP, NKE, MU, SIG, TPX, TPR, WYNN\nBoosted stakes in: AMZN, ATVI, ALGN, LYV, LH, EXPE, SEAS, SNOW, PVH, TXRH\nCut stakes in: MA, FB, BBWI, GOOGL, SBUX, UBER, FICO, NTES, HLT, NOW\n\nOMEGA ADVISORS\n\nTop new buys: LAD, BHC, VOO, PFSI, EFA, IVW, COG, SCHO, IEUR, EWJ\nTop exits: MGY, IFF, CMCSA\nBoosted stakes in: FOA, WSC, VRT, NRG, PXD, ABR, ASH, ASPU, BABA, FLMN\nCut stakes in: FOE, NAVI, OCN, TRN, BBDC, FCRD, SRGA, FB, SNR\n\nPERSHING SQUARE\n\nBoosted stakes in: DPZ\nCut stakes in: LOW, QSR, HLT, A\n\nSOROBAN CAPITAL\n\nTop new buys: FB, TWTR, NFLX, WAB, KAHC, LGV, BKI, PLNT, MSDA, TIOA\nTop exits: BABA, CMCSA, DPZ, RTX, GRA, GWRE, ALIT, SFTW, SPFR\nBoosted stakes in: LOW, CSX, ADI, UNP, FIS, VYGG, BTNB\nCut stakes in: ATUS, SPGI, PAYO, KVSB, ME, SUNL, BGRY, GNAC, DOMA, NSH\n\nSOROS FUND MANAGEMENT\n\nTop new buys: FIGS, INFO, PTRA, MQ, PPD, VER, NUAN, MGLN, INDI, ACN\nTop exits: BIDU, DEN, VIPS, TME, IQ, DISCK, XLE, MU, ASHR, WAL\nBoosted stakes in: AMZN, MXIM, ELAN, GOOGL, CLVT, DIS, OPEN, W, CRM, SYF\nCut stakes in: LQD, QS, VICI, UPST, TXN, LVS, ADI, NXPI, DHI, LPLA\n\nSTARBOARD\n\nTop new buys: PZZA, WPCB, LEGA, KAHC, SLAM, FRXB, ATMR, ROSS, MACC, ACAH\nBoosted stakes in: CERN, BOX, IWM, IWR, TWCT, KVSC, DGNU, PRPB, LNFA, ON\nCut stakes in: CTVA, IWN, ACM, MAAC, SCOR, NLOK, MMSI, ELAN, CVLT\n\nTEMASEK HOLDINGS\n\nTop new buys: ABNB, INTA, FLYW, PAYO, KRE, STEM, LCTU, INTC, SOFI, COPX\nTop exits: XLF, ADBE, INDA, EWZ, ACIU, PCVX\nBoosted stakes in: BILL, BEAM, TMO, DELL, EWY, IBN, IAU, CRM, SNOW, AFRM\nCut stakes in: WISH, IWM, BABA, MSFT, XLB, CTVA, DASH, RBLX\n\nTHIRD POINT\n\nTop new buys: S, SOFI, EDR, ZBH, PTON, RTPY, JWSM, ASZ, IACC, AUS\nTop exits: IAA, RACE, KMX, Z, SHOP, CVNA, ETRN, NYT, WISH, RKT\nBoosted stakes in: INTC, AMZN, DELL, CANO, EL, UBER, SU, RH, DD, AES\nCut stakes in: CHTR, PCG, JD, IQV, DIS, RADI, APTV, BOAC, MTTR, TEL\n\nTIGER GLOBAL\n\nTop new buys: PCOR, PATH, COIN, DV, BHG, DLO, APP, S, GRUB, KPLT\nTop exits: ASO\nBoosted stakes in: DASH, DOCU, ZM, SHOP, SE, SNOW, CVNA, PTON, YSG, RNG\nCut stakes in: CRM, TAL, JD, EDU, RBLX, GDS, UBER, DESP, BABA, RDFN","news_type":1},"isVote":1,"tweetType":1,"viewCount":445,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":890373633,"gmtCreate":1628085221622,"gmtModify":1703500942624,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NVAX\">$Novavax(NVAX)$</a>to the moon!","listText":"<a href=\"https://laohu8.com/S/NVAX\">$Novavax(NVAX)$</a>to the moon!","text":"$Novavax(NVAX)$to the moon!","images":[{"img":"https://static.tigerbbs.com/cce04145b5b0ff63db9941caf8f1bb57","width":"1125","height":"2183"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/890373633","isVote":1,"tweetType":1,"viewCount":402,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":141117570,"gmtCreate":1625841883290,"gmtModify":1703749724577,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MTCH\">$Match(MTCH)$</a>yay!","listText":"<a href=\"https://laohu8.com/S/MTCH\">$Match(MTCH)$</a>yay!","text":"$Match(MTCH)$yay!","images":[{"img":"https://static.tigerbbs.com/0aee2c6706438205a70646f687086ac4","width":"1125","height":"2183"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/141117570","isVote":1,"tweetType":1,"viewCount":536,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":156771898,"gmtCreate":1625238755214,"gmtModify":1703739253097,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/156771898","repostId":"1115261715","repostType":2,"repost":{"id":"1115261715","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1625125255,"share":"https://ttm.financial/m/news/1115261715?lang=&edition=fundamental","pubTime":"2021-07-01 15:40","market":"us","language":"en","title":"Look back to the first half of the year: U.S. stock indexs hit record high, these stocks are winner","url":"https://stock-news.laohu8.com/highlight/detail?id=1115261715","media":"Tiger Newspress","summary":"(July 1) The global market officially ended in the first half of the year. On the whole, the French ","content":"<p>(July&nbsp;1)&nbsp;The global market officially ended in the first half of the year. On the whole, the French CAC 40 index took the lead with an increase of 17.2%; the S&amp;P 500 index and the Eurozone Stoxx 50 index increased by 14.4% Tied for second place; followed by the Mexico Composite Index and the German DAX 30 Index, with gains of 14.1% and 13.2%, respectively.</p>\n<p><img src=\"https://static.tigerbbs.com/b0699623d049666a5b8b1af052f8e0d8\" tg-width=\"670\" tg-height=\"1408\" referrerpolicy=\"no-referrer\"></p>\n<p><b>U.S. stock indexes hit record high, energy stocks are winners</b></p>\n<p>U.S. stocks in the first half of the year generally showed a trend of volatility and upward movement. The three major indexes jointly set a new record high. The S&amp;P 500 index rose by 14.41% in the first half of the year, which has outperformed the index's average annual growth rate of 11% in the past two decades, and far outpaced the 4% increase in the first half of last year; the Nasdaq index rose by 12.54 % in the first half of the year, the Dow Jones index rose 12.73%.</p>\n<p>From the perspective of sectors and individual stocks, \"economic recovery\" and \"increasing inflation\" are the two main factors&nbsp;that dominated the U.S. stock market in the first half of the year. Under the influence of these two main factors, energy stocks, finance stocks and real estate stocks outperformed other sectors.</p>\n<p><img src=\"https://static.tigerbbs.com/4697acc988167e0c0adfe0713ce52b64\" tg-width=\"1924\" tg-height=\"1080\" referrerpolicy=\"no-referrer\"></p>\n<p>In the first half of this year, with the gradual promotion of the global vaccinations against the new crown, China took the lead in getting out of the shadow of the epidemic, and many European and American countries have gradually begun to loosen their blockades. With the recovery of global economy and the rebound in demand for commodities, especially the rapid rise in energy demand, Brent crude oil is the best performing asset in the first half of the year, with a yield of 44.32%.</p>\n<p>Benefiting from the explosion of demand, US energy stocks are also the top performers. Among the S&amp;P 500 constituent stocks, five of the top ten gainers are energy stocks. Among them, Marathon Petroleum ranked first with a half-year increase of 105.55%. The other four are Diamondback Energy, Devon Energy, Occidental Petroleum and EOG Energy, with increases of 96.07%, 91.64%, 80.77% and 69.30% respectively.</p>\n<p><img src=\"https://static.tigerbbs.com/bf9454f083cdbfc0296a0d9c53d53fe6\" tg-width=\"1924\" tg-height=\"1082\" referrerpolicy=\"no-referrer\"></p>\n<p>In addition, among the constituent stocks of the Dow, energy stocks are also among the top performers. Chevron ranked fourth with an increase of 27.32%, and Caterpillar ranked eighth with an increase of 20.74%. Among the constituent stocks of the Dow, the performance of bank stocks is also remarkable.</p>\n<p>Bank stocks performed very well during the epidemic, with the help of legislators and the Federal Reserve. Three of the top five companies in the Dow's gainers are bank stocks. Among them, Goldman Sachs ranked first with increaing 44.97%; American Express ranked second with a 37.55% increase, and JPMorgan Chase ranked fifth with a 24.01% increase.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Look back to the first half of the year: U.S. stock indexs hit record high, these stocks are winner</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLook back to the first half of the year: U.S. stock indexs hit record high, these stocks are winner\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-07-01 15:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(July&nbsp;1)&nbsp;The global market officially ended in the first half of the year. On the whole, the French CAC 40 index took the lead with an increase of 17.2%; the S&amp;P 500 index and the Eurozone Stoxx 50 index increased by 14.4% Tied for second place; followed by the Mexico Composite Index and the German DAX 30 Index, with gains of 14.1% and 13.2%, respectively.</p>\n<p><img src=\"https://static.tigerbbs.com/b0699623d049666a5b8b1af052f8e0d8\" tg-width=\"670\" tg-height=\"1408\" referrerpolicy=\"no-referrer\"></p>\n<p><b>U.S. stock indexes hit record high, energy stocks are winners</b></p>\n<p>U.S. stocks in the first half of the year generally showed a trend of volatility and upward movement. The three major indexes jointly set a new record high. The S&amp;P 500 index rose by 14.41% in the first half of the year, which has outperformed the index's average annual growth rate of 11% in the past two decades, and far outpaced the 4% increase in the first half of last year; the Nasdaq index rose by 12.54 % in the first half of the year, the Dow Jones index rose 12.73%.</p>\n<p>From the perspective of sectors and individual stocks, \"economic recovery\" and \"increasing inflation\" are the two main factors&nbsp;that dominated the U.S. stock market in the first half of the year. Under the influence of these two main factors, energy stocks, finance stocks and real estate stocks outperformed other sectors.</p>\n<p><img src=\"https://static.tigerbbs.com/4697acc988167e0c0adfe0713ce52b64\" tg-width=\"1924\" tg-height=\"1080\" referrerpolicy=\"no-referrer\"></p>\n<p>In the first half of this year, with the gradual promotion of the global vaccinations against the new crown, China took the lead in getting out of the shadow of the epidemic, and many European and American countries have gradually begun to loosen their blockades. With the recovery of global economy and the rebound in demand for commodities, especially the rapid rise in energy demand, Brent crude oil is the best performing asset in the first half of the year, with a yield of 44.32%.</p>\n<p>Benefiting from the explosion of demand, US energy stocks are also the top performers. Among the S&amp;P 500 constituent stocks, five of the top ten gainers are energy stocks. Among them, Marathon Petroleum ranked first with a half-year increase of 105.55%. The other four are Diamondback Energy, Devon Energy, Occidental Petroleum and EOG Energy, with increases of 96.07%, 91.64%, 80.77% and 69.30% respectively.</p>\n<p><img src=\"https://static.tigerbbs.com/bf9454f083cdbfc0296a0d9c53d53fe6\" tg-width=\"1924\" tg-height=\"1082\" referrerpolicy=\"no-referrer\"></p>\n<p>In addition, among the constituent stocks of the Dow, energy stocks are also among the top performers. Chevron ranked fourth with an increase of 27.32%, and Caterpillar ranked eighth with an increase of 20.74%. Among the constituent stocks of the Dow, the performance of bank stocks is also remarkable.</p>\n<p>Bank stocks performed very well during the epidemic, with the help of legislators and the Federal Reserve. Three of the top five companies in the Dow's gainers are bank stocks. Among them, Goldman Sachs ranked first with increaing 44.97%; American Express ranked second with a 37.55% increase, and JPMorgan Chase ranked fifth with a 24.01% increase.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite","SPY":"标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115261715","content_text":"(July 1) The global market officially ended in the first half of the year. On the whole, the French CAC 40 index took the lead with an increase of 17.2%; the S&P 500 index and the Eurozone Stoxx 50 index increased by 14.4% Tied for second place; followed by the Mexico Composite Index and the German DAX 30 Index, with gains of 14.1% and 13.2%, respectively.\n\nU.S. stock indexes hit record high, energy stocks are winners\nU.S. stocks in the first half of the year generally showed a trend of volatility and upward movement. The three major indexes jointly set a new record high. The S&P 500 index rose by 14.41% in the first half of the year, which has outperformed the index's average annual growth rate of 11% in the past two decades, and far outpaced the 4% increase in the first half of last year; the Nasdaq index rose by 12.54 % in the first half of the year, the Dow Jones index rose 12.73%.\nFrom the perspective of sectors and individual stocks, \"economic recovery\" and \"increasing inflation\" are the two main factors that dominated the U.S. stock market in the first half of the year. Under the influence of these two main factors, energy stocks, finance stocks and real estate stocks outperformed other sectors.\n\nIn the first half of this year, with the gradual promotion of the global vaccinations against the new crown, China took the lead in getting out of the shadow of the epidemic, and many European and American countries have gradually begun to loosen their blockades. With the recovery of global economy and the rebound in demand for commodities, especially the rapid rise in energy demand, Brent crude oil is the best performing asset in the first half of the year, with a yield of 44.32%.\nBenefiting from the explosion of demand, US energy stocks are also the top performers. Among the S&P 500 constituent stocks, five of the top ten gainers are energy stocks. Among them, Marathon Petroleum ranked first with a half-year increase of 105.55%. The other four are Diamondback Energy, Devon Energy, Occidental Petroleum and EOG Energy, with increases of 96.07%, 91.64%, 80.77% and 69.30% respectively.\n\nIn addition, among the constituent stocks of the Dow, energy stocks are also among the top performers. Chevron ranked fourth with an increase of 27.32%, and Caterpillar ranked eighth with an increase of 20.74%. Among the constituent stocks of the Dow, the performance of bank stocks is also remarkable.\nBank stocks performed very well during the epidemic, with the help of legislators and the Federal Reserve. Three of the top five companies in the Dow's gainers are bank stocks. Among them, Goldman Sachs ranked first with increaing 44.97%; American Express ranked second with a 37.55% increase, and JPMorgan Chase ranked fifth with a 24.01% increase.","news_type":1},"isVote":1,"tweetType":1,"viewCount":283,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":156544825,"gmtCreate":1625232759967,"gmtModify":1703738963658,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"[Surprised]&nbsp;","listText":"[Surprised]&nbsp;","text":"[Surprised]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/156544825","repostId":"1126312436","repostType":4,"repost":{"id":"1126312436","kind":"news","pubTimestamp":1625212145,"share":"https://ttm.financial/m/news/1126312436?lang=&edition=fundamental","pubTime":"2021-07-02 15:49","market":"us","language":"en","title":"The Stock Market Had a Great First Half. 3 Things That Could Cause it to Crash.","url":"https://stock-news.laohu8.com/highlight/detail?id=1126312436","media":"Barrons","summary":"Stocks have soared relentlessly this year. Several factors, however, have the potential to end the p","content":"<p>Stocks have soared relentlessly this year. Several factors, however, have the potential to end the party.</p>\n<p>The S&amp;P 500 has had its second-best first half of a year since 1998, and it hasn’t shown many signs of letting up. The index ended June up 14.4% year to date, hitting several records during the month and posting another record close on Thursday.</p>\n<p>Yet there are a couple key risks that could turn all of that around, according to Nick Colas, co-founder of DataTrek.</p>\n<p>First, there’s the possibility of an oil price shock, as the price of crude has shown little sign of cooling off. WTI crude oil is up 56% year to date and notched a&nbsp;new multi-year high&nbsp;Thursday—even amid growing&nbsp;expectations that OPEC will increase supply. If oil prices run hot enough, that could raise inflation to a level that—if sustained — could cause consumer demand to fall and that could surpass Federal Reserve expectations.</p>\n<p>“Suddenly higher oil prices” is atop the list of stock market concerns for Colas. “Rapidly rising oil prices will cause U.S. inflation to overshoot the Fed’s desired outcome and also stress the American consumer.”</p>\n<p>Both those things could dent the stock market, which has long benefited from the Fed’s accommodative monetary policy, especially if the Fed signals that interest-rate increases could come sooner than expected.</p>\n<p>That means the Fed will need to tread carefully when discussing rates to avoid spooking the market, Colas says.</p>\n<p>“Federal Reserve miscommunication about upcoming policy changes and/or raising interest rates too aggressively” is a second risk, Colas says. For instance, the S&amp;P 500&nbsp;dived 18% over roughly three months in late 2018 as the Fed raised rates, despite the market’s hope at that time for rates to stay put.</p>\n<p>Peaking earnings growth is the other threat to stocks, Colas says. Earnings growth for the average S&amp;P 500 company is expected slow down to 11% in 2022 from 36% in 2021, according to FactSet, as the economy normalizes and the postpandemic recovery eases. But on average, S&amp;P 500 stocks trade at 21.5 times expected earnings for the next 12 months, still above the index’s pre-pandemic multiple. At some point, stocks valuations will need to better reflect the expected decline in earnings growth, which would mean falling stock prices.</p>\n<p>“Valuations are high enough currently that peaking earnings could be a larger risk than before,” Colas writes.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Stock Market Had a Great First Half. 3 Things That Could Cause it to Crash.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Stock Market Had a Great First Half. 3 Things That Could Cause it to Crash.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-02 15:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/stock-market-crash-risks-51625174065><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stocks have soared relentlessly this year. Several factors, however, have the potential to end the party.\nThe S&P 500 has had its second-best first half of a year since 1998, and it hasn’t shown many ...</p>\n\n<a href=\"https://www.barrons.com/articles/stock-market-crash-risks-51625174065\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"https://www.barrons.com/articles/stock-market-crash-risks-51625174065","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1126312436","content_text":"Stocks have soared relentlessly this year. Several factors, however, have the potential to end the party.\nThe S&P 500 has had its second-best first half of a year since 1998, and it hasn’t shown many signs of letting up. The index ended June up 14.4% year to date, hitting several records during the month and posting another record close on Thursday.\nYet there are a couple key risks that could turn all of that around, according to Nick Colas, co-founder of DataTrek.\nFirst, there’s the possibility of an oil price shock, as the price of crude has shown little sign of cooling off. WTI crude oil is up 56% year to date and notched a new multi-year high Thursday—even amid growing expectations that OPEC will increase supply. If oil prices run hot enough, that could raise inflation to a level that—if sustained — could cause consumer demand to fall and that could surpass Federal Reserve expectations.\n“Suddenly higher oil prices” is atop the list of stock market concerns for Colas. “Rapidly rising oil prices will cause U.S. inflation to overshoot the Fed’s desired outcome and also stress the American consumer.”\nBoth those things could dent the stock market, which has long benefited from the Fed’s accommodative monetary policy, especially if the Fed signals that interest-rate increases could come sooner than expected.\nThat means the Fed will need to tread carefully when discussing rates to avoid spooking the market, Colas says.\n“Federal Reserve miscommunication about upcoming policy changes and/or raising interest rates too aggressively” is a second risk, Colas says. For instance, the S&P 500 dived 18% over roughly three months in late 2018 as the Fed raised rates, despite the market’s hope at that time for rates to stay put.\nPeaking earnings growth is the other threat to stocks, Colas says. Earnings growth for the average S&P 500 company is expected slow down to 11% in 2022 from 36% in 2021, according to FactSet, as the economy normalizes and the postpandemic recovery eases. But on average, S&P 500 stocks trade at 21.5 times expected earnings for the next 12 months, still above the index’s pre-pandemic multiple. At some point, stocks valuations will need to better reflect the expected decline in earnings growth, which would mean falling stock prices.\n“Valuations are high enough currently that peaking earnings could be a larger risk than before,” Colas writes.","news_type":1},"isVote":1,"tweetType":1,"viewCount":195,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":126731704,"gmtCreate":1624584113808,"gmtModify":1703840929351,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"Awesome!","listText":"Awesome!","text":"Awesome!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/126731704","repostId":"2145042230","repostType":4,"repost":{"id":"2145042230","kind":"news","pubTimestamp":1624578900,"share":"https://ttm.financial/m/news/2145042230?lang=&edition=fundamental","pubTime":"2021-06-25 07:55","market":"us","language":"en","title":"Eli Lilly Surges After Getting Breakthrough Therapy Designation From FDA, Analyst Raises PT and Sees Approval Chance at 90%, Biogen Plunges","url":"https://stock-news.laohu8.com/highlight/detail?id=2145042230","media":"StreetInsider","summary":"Shares of Eli Lilly and Company (NYSE: LLY) are up over 9% in today’s trading session after the comp","content":"<p>Shares of Eli Lilly and Company (NYSE: LLY) are up over 9% in today’s trading session after the company obtained the Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for donanemab, the company’s investigational antibody therapy for Alzheimer's disease (AD).</p>\n<p>This designation is granted to companies in a bid to accelerate the development and review of therapies meant to treat serious conditions when preliminary clinical results show that the relevant drug is ahead of already available therapies that have received full FDA approval.</p>\n<p>Donanemab is an investigational antibody treatment developed by Lilly’s that targets a modified form of beta-amyloid named N3pG. In its Phase 2 trial, the company studied the efficacy and safety of the drug in patients with early Alzheimer’s disease.</p>\n<p>Stifel analyst Paul Matteis says the designation has “multiple implications for the sector.” Shares of Biogen (NASDAQ: BIIB) are down over 5% on LLY news.</p>\n<p>“LLY's plans to file donanemab this morning for accelerated approval later this year is somewhat surprising to us from a timing perspective, not because of the efficacy data (good enough relative to Adu), but because we were unsure whether the FDA would be comfortable with the size of the safety dataset. This has multiple implications for BIIB (incrementally negative) and the abeta space,” the analyst said in a note.</p>\n<p>“On the <a href=\"https://laohu8.com/S/AONE\">one</a> hand, it increases competition for BIIB: LLY's actual clinical data are less confusing, and Biogen is mired in a string of bad press regarding pricing; competition could drive down the net price. Meanwhile, it also may impact the multiple that investors put in anti-amyloid agent revenues in general. Biogen has 9 years to complete its confirmatory trial; however, LLY's second donanemab study is ongoing and may readout considerably sooner, and may set up as a relevant catalyst, positive or negative, for the plight of both drugs.”</p>\n<p>Mizuho analyst Vamil Divan raised the price target on the Buy-rated LLY to $250.00 per share from $216.00 per share as “it is difficult to argue why donanemab would NOT be approved, given the speed and depth of plaque clearance donanemab demonstrated in TRAILBLAZER-ALZ and prior studies.”</p>\n<p>“We increase our probability of donanemab's regulatory approval to 90% (from 60%), assuming an accelerated approval will be based on amyloid plaque clearance, something donanemab has already consistently demonstrated. We also move up our donanemab launch to the start of 2023 (from 2024), but acknowledge this could even prove to still be a little conservative. However, we note that BIIB has guided to only “modest” revenues this year after its June 7 approval, so would assume fairly limited donanemab sales in 2022 even if Lilly gets an approval in the middle of the year. On the other hand, Lilly may be able to leverage some of what BIIB is doing now to secure coverage and access for anti-amyloid therapies, allowing for potentially more rapid market uptake. Lilly would also have the potential advantage of having confirmatory clinical data much sooner than BIIB, given their TRAILBLAZER-ALZ 2 trial is ongoing, with recruitment expected to be completed by year-end and full data expected by mid-2023,” Divan writes in a report on LLY.</p>\n<p>“We now estimate donanemab probability-adjusted sales of ~$11Bn in 2030, with room for further upside given the size of the Alzheimer's market. Our donanemab estimate changes drive our Lilly price target to $250 (from $217), with room for upside on a faster approval, a higher price (we currently assume $30K net per patient per year in the US and $15K in the EU and Japan), more rapid market uptake and/or higher peak sales. Our price target based on a 75%/25% blend of discounted cash flow (DCF) valuation at $259 and relative valuation at $222. Our DCF is based on cash flows forecasted through 2030, along with a 6.5% discount rate and a 0.5% rate of terminal growth. Our relative valuation is based on a 30.0x multiple of 2021 P/E using our estimate of Lilly’s 2021 EPS.”</p>\n<p>Lilly plans to apply for the biologics license (BLA) for donanemab under the expedited approval pathway later in 2021 based on data from Phase 2. The safety and efficacy of the drug are also being assessed in the ongoing Phase 3 study.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Surges After Getting Breakthrough Therapy Designation From FDA, Analyst Raises PT and Sees Approval Chance at 90%, Biogen Plunges</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Surges After Getting Breakthrough Therapy Designation From FDA, Analyst Raises PT and Sees Approval Chance at 90%, Biogen Plunges\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 07:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18600310><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Eli Lilly and Company (NYSE: LLY) are up over 9% in today’s trading session after the company obtained the Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18600310\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司","LLY":"礼来"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18600310","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2145042230","content_text":"Shares of Eli Lilly and Company (NYSE: LLY) are up over 9% in today’s trading session after the company obtained the Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for donanemab, the company’s investigational antibody therapy for Alzheimer's disease (AD).\nThis designation is granted to companies in a bid to accelerate the development and review of therapies meant to treat serious conditions when preliminary clinical results show that the relevant drug is ahead of already available therapies that have received full FDA approval.\nDonanemab is an investigational antibody treatment developed by Lilly’s that targets a modified form of beta-amyloid named N3pG. In its Phase 2 trial, the company studied the efficacy and safety of the drug in patients with early Alzheimer’s disease.\nStifel analyst Paul Matteis says the designation has “multiple implications for the sector.” Shares of Biogen (NASDAQ: BIIB) are down over 5% on LLY news.\n“LLY's plans to file donanemab this morning for accelerated approval later this year is somewhat surprising to us from a timing perspective, not because of the efficacy data (good enough relative to Adu), but because we were unsure whether the FDA would be comfortable with the size of the safety dataset. This has multiple implications for BIIB (incrementally negative) and the abeta space,” the analyst said in a note.\n“On the one hand, it increases competition for BIIB: LLY's actual clinical data are less confusing, and Biogen is mired in a string of bad press regarding pricing; competition could drive down the net price. Meanwhile, it also may impact the multiple that investors put in anti-amyloid agent revenues in general. Biogen has 9 years to complete its confirmatory trial; however, LLY's second donanemab study is ongoing and may readout considerably sooner, and may set up as a relevant catalyst, positive or negative, for the plight of both drugs.”\nMizuho analyst Vamil Divan raised the price target on the Buy-rated LLY to $250.00 per share from $216.00 per share as “it is difficult to argue why donanemab would NOT be approved, given the speed and depth of plaque clearance donanemab demonstrated in TRAILBLAZER-ALZ and prior studies.”\n“We increase our probability of donanemab's regulatory approval to 90% (from 60%), assuming an accelerated approval will be based on amyloid plaque clearance, something donanemab has already consistently demonstrated. We also move up our donanemab launch to the start of 2023 (from 2024), but acknowledge this could even prove to still be a little conservative. However, we note that BIIB has guided to only “modest” revenues this year after its June 7 approval, so would assume fairly limited donanemab sales in 2022 even if Lilly gets an approval in the middle of the year. On the other hand, Lilly may be able to leverage some of what BIIB is doing now to secure coverage and access for anti-amyloid therapies, allowing for potentially more rapid market uptake. Lilly would also have the potential advantage of having confirmatory clinical data much sooner than BIIB, given their TRAILBLAZER-ALZ 2 trial is ongoing, with recruitment expected to be completed by year-end and full data expected by mid-2023,” Divan writes in a report on LLY.\n“We now estimate donanemab probability-adjusted sales of ~$11Bn in 2030, with room for further upside given the size of the Alzheimer's market. Our donanemab estimate changes drive our Lilly price target to $250 (from $217), with room for upside on a faster approval, a higher price (we currently assume $30K net per patient per year in the US and $15K in the EU and Japan), more rapid market uptake and/or higher peak sales. Our price target based on a 75%/25% blend of discounted cash flow (DCF) valuation at $259 and relative valuation at $222. Our DCF is based on cash flows forecasted through 2030, along with a 6.5% discount rate and a 0.5% rate of terminal growth. Our relative valuation is based on a 30.0x multiple of 2021 P/E using our estimate of Lilly’s 2021 EPS.”\nLilly plans to apply for the biologics license (BLA) for donanemab under the expedited approval pathway later in 2021 based on data from Phase 2. The safety and efficacy of the drug are also being assessed in the ongoing Phase 3 study.","news_type":1},"isVote":1,"tweetType":1,"viewCount":109,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":126491661,"gmtCreate":1624580840353,"gmtModify":1703840771095,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"[Surprised]&nbsp;","listText":"[Surprised]&nbsp;","text":"[Surprised]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/126491661","repostId":"1151333793","repostType":4,"repost":{"id":"1151333793","kind":"news","pubTimestamp":1624578319,"share":"https://ttm.financial/m/news/1151333793?lang=&edition=fundamental","pubTime":"2021-06-25 07:45","market":"us","language":"en","title":"Nike forecast for online sales boom, post-lockdown demand drives shares up 13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1151333793","media":"Reuters","summary":"(Reuters) -Nike Inc on Thursday forecast fiscal full-year sales ahead of Wall Street estimates, bett","content":"<p>(Reuters) -Nike Inc on Thursday forecast fiscal full-year sales ahead of Wall Street estimates, betting on its online business, higher demand as lockdowns ease, and its tried-and-tested strategy of limiting stock for popular products.</p>\n<p>The sneaker maker’s shares rose nearly 13% after the bell as the company also posted better-than-expected quarterly earnings and revenue.</p>\n<p>After staying at home for more than a year and limiting themselves to leisure-wear and comfortable pajamas, consumers are back to buying sneakers for running and hiking as they return to their routines, thanks to rapid vaccinations.</p>\n<p>There were definite reasons for optimism and confidence, like the return to sport, Chief Financial Officer Matthew Friend said on an earnings call, adding that Nike has already begun to see an acceleration in its sport performance business.</p>\n<p>Beaverton, Oregon-based Nike said fiscal 2022 revenue is estimated to grow by low double-digits and surpass $50 billion. Analysts had expected revenue of $48.46 billion for fiscal 2022, according to Refinitiv.</p>\n<p>First-half growth is expected to be slightly higher than second half growth, Friend said.</p>\n<p>In Nike’s biggest market, North America, fourth-quarter revenue more than doubled to $5.38 billion and beat the average analysts’ estimate of $4.31 billion.</p>\n<p>Total gross margin rose 8.5 percentage points to 45.8% versus last year, boosted in part by the company’s direct to consumer business and fewer charges related to factory cancellations. Analysts expected gross margin of 43.96%, according to Refinitiv.</p>\n<p>Net income came in at $1.51 billion, or 93 cents per share, for the quarter ended May 31, compared with a loss of $790 million, or 51 cents per share, a year earlier.</p>\n<p>Total revenue nearly doubled to $12.34 billion from a year ago, when the pandemic was at its peak. Analysts were expecting revenue of $11.01 billion and earnings of 51 cents per share, according to IBES data from Refinitiv.</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nike forecast for online sales boom, post-lockdown demand drives shares up 13%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNike forecast for online sales boom, post-lockdown demand drives shares up 13%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 07:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/article/nike-results/update-3-nike-forecast-for-online-sales-boom-post-lockdown-demand-drives-shares-up-13-idUSL3N2O63ZI><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) -Nike Inc on Thursday forecast fiscal full-year sales ahead of Wall Street estimates, betting on its online business, higher demand as lockdowns ease, and its tried-and-tested strategy of ...</p>\n\n<a href=\"https://www.reuters.com/article/nike-results/update-3-nike-forecast-for-online-sales-boom-post-lockdown-demand-drives-shares-up-13-idUSL3N2O63ZI\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NKE":"耐克"},"source_url":"https://www.reuters.com/article/nike-results/update-3-nike-forecast-for-online-sales-boom-post-lockdown-demand-drives-shares-up-13-idUSL3N2O63ZI","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151333793","content_text":"(Reuters) -Nike Inc on Thursday forecast fiscal full-year sales ahead of Wall Street estimates, betting on its online business, higher demand as lockdowns ease, and its tried-and-tested strategy of limiting stock for popular products.\nThe sneaker maker’s shares rose nearly 13% after the bell as the company also posted better-than-expected quarterly earnings and revenue.\nAfter staying at home for more than a year and limiting themselves to leisure-wear and comfortable pajamas, consumers are back to buying sneakers for running and hiking as they return to their routines, thanks to rapid vaccinations.\nThere were definite reasons for optimism and confidence, like the return to sport, Chief Financial Officer Matthew Friend said on an earnings call, adding that Nike has already begun to see an acceleration in its sport performance business.\nBeaverton, Oregon-based Nike said fiscal 2022 revenue is estimated to grow by low double-digits and surpass $50 billion. Analysts had expected revenue of $48.46 billion for fiscal 2022, according to Refinitiv.\nFirst-half growth is expected to be slightly higher than second half growth, Friend said.\nIn Nike’s biggest market, North America, fourth-quarter revenue more than doubled to $5.38 billion and beat the average analysts’ estimate of $4.31 billion.\nTotal gross margin rose 8.5 percentage points to 45.8% versus last year, boosted in part by the company’s direct to consumer business and fewer charges related to factory cancellations. Analysts expected gross margin of 43.96%, according to Refinitiv.\nNet income came in at $1.51 billion, or 93 cents per share, for the quarter ended May 31, compared with a loss of $790 million, or 51 cents per share, a year earlier.\nTotal revenue nearly doubled to $12.34 billion from a year ago, when the pandemic was at its peak. Analysts were expecting revenue of $11.01 billion and earnings of 51 cents per share, according to IBES data from Refinitiv.","news_type":1},"isVote":1,"tweetType":1,"viewCount":293,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":126920343,"gmtCreate":1624542568182,"gmtModify":1703839849966,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"[Miser]&nbsp;","listText":"[Miser]&nbsp;","text":"[Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/126920343","repostId":"1186095717","repostType":4,"repost":{"id":"1186095717","kind":"news","pubTimestamp":1624538824,"share":"https://ttm.financial/m/news/1186095717?lang=&edition=fundamental","pubTime":"2021-06-24 20:47","market":"us","language":"en","title":"IPO Watch: Bright Health, Monte Rosa, Confluent to Start Trading Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1186095717","media":"The Wall Street Journal","summary":"Bright Health Group will start trading on the NYSE today under the ticker BHG. The company sold shar","content":"<p>Bright Health Group will start trading on the NYSE today under the ticker BHG. The company sold shares in its initial public offering at $18 apiece.</p>\n<p>Monte Rosa Therapeutics Inc. will join the Nasdaq Global Select Market as GLUE after selling shares at $19 each.</p>\n<p>Confluent Inc. will make its debut as CFLT. The company's shares were sold in the IPO for $36 each.</p>\n<p>Miromatrix Medical will make its debut on the Nasdaq as MIRO after selling shares at $9 each.</p>\n<p>Grove Inc. will trade as GRVI after selling its stock in the IPO at $5 apiece.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IPO Watch: Bright Health, Monte Rosa, Confluent to Start Trading Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIPO Watch: Bright Health, Monte Rosa, Confluent to Start Trading Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 20:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/ktmYlQj6UfmkqxIEmORt><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Bright Health Group will start trading on the NYSE today under the ticker BHG. The company sold shares in its initial public offering at $18 apiece.\nMonte Rosa Therapeutics Inc. will join the Nasdaq ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/ktmYlQj6UfmkqxIEmORt\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CFLT":"Confluent, Inc.","GLUE":"Monte Rosa Therapeutics"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/ktmYlQj6UfmkqxIEmORt","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1186095717","content_text":"Bright Health Group will start trading on the NYSE today under the ticker BHG. The company sold shares in its initial public offering at $18 apiece.\nMonte Rosa Therapeutics Inc. will join the Nasdaq Global Select Market as GLUE after selling shares at $19 each.\nConfluent Inc. will make its debut as CFLT. The company's shares were sold in the IPO for $36 each.\nMiromatrix Medical will make its debut on the Nasdaq as MIRO after selling shares at $9 each.\nGrove Inc. will trade as GRVI after selling its stock in the IPO at $5 apiece.","news_type":1},"isVote":1,"tweetType":1,"viewCount":223,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":128591727,"gmtCreate":1624522398269,"gmtModify":1703839216133,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/128591727","repostId":"1114144195","repostType":4,"repost":{"id":"1114144195","kind":"news","pubTimestamp":1624522045,"share":"https://ttm.financial/m/news/1114144195?lang=&edition=fundamental","pubTime":"2021-06-24 16:07","market":"sg","language":"en","title":"Temasek-backed online pharmacy seeks funds at US$4b valuation: sources","url":"https://stock-news.laohu8.com/highlight/detail?id=1114144195","media":"Bloomberg","summary":"[MAHARASHTRA] API Holdings is weighing a new funding round that could value the owner of India's lar","content":"<p>[MAHARASHTRA] API Holdings is weighing a new funding round that could value the owner of India's largest online pharmacy chain at about US$4 billion, according to people familiar with the matter.</p>\n<p>The company is considering raising about US$300 million and its existing investors including TPG Capital and Temasek Holdings could participate, said the people, who asked not to be identified as the discussions are private.</p>\n<p>API, which owns India's first e-pharmacy unicorn PharmEasy, intends to use the proceeds for potential acquisitions particularly in the diagnostic area, one of the people said.</p>\n<p>A new round would mark the second fundraising by API Holdings within a few months after securing about US$350 million in April. The firm last raised funds from a clutch of investors including Prosus Ventures, TPG and Temasek, according to a press release at that time.</p>\n<p>PharmEasy has so far delivered more than 15 million orders from medicine to diagnostic kits to healthcare products, serving over five million families, according to its website.</p>\n<p>Deliberations are ongoing and details of the fundraising could still change, the people said. Siddharth Shah, API's co-founder and chief executive officer, didn't respond to messages for comment, while representatives for Temasek and TPG declined to comment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Temasek-backed online pharmacy seeks funds at US$4b valuation: sources</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTemasek-backed online pharmacy seeks funds at US$4b valuation: sources\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 16:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.businesstimes.com.sg/garage/temasek-backed-online-pharmacy-seeks-funds-at-us4b-valuation-sources><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>[MAHARASHTRA] API Holdings is weighing a new funding round that could value the owner of India's largest online pharmacy chain at about US$4 billion, according to people familiar with the matter.\nThe ...</p>\n\n<a href=\"https://www.businesstimes.com.sg/garage/temasek-backed-online-pharmacy-seeks-funds-at-us4b-valuation-sources\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.businesstimes.com.sg/garage/temasek-backed-online-pharmacy-seeks-funds-at-us4b-valuation-sources","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114144195","content_text":"[MAHARASHTRA] API Holdings is weighing a new funding round that could value the owner of India's largest online pharmacy chain at about US$4 billion, according to people familiar with the matter.\nThe company is considering raising about US$300 million and its existing investors including TPG Capital and Temasek Holdings could participate, said the people, who asked not to be identified as the discussions are private.\nAPI, which owns India's first e-pharmacy unicorn PharmEasy, intends to use the proceeds for potential acquisitions particularly in the diagnostic area, one of the people said.\nA new round would mark the second fundraising by API Holdings within a few months after securing about US$350 million in April. The firm last raised funds from a clutch of investors including Prosus Ventures, TPG and Temasek, according to a press release at that time.\nPharmEasy has so far delivered more than 15 million orders from medicine to diagnostic kits to healthcare products, serving over five million families, according to its website.\nDeliberations are ongoing and details of the fundraising could still change, the people said. Siddharth Shah, API's co-founder and chief executive officer, didn't respond to messages for comment, while representatives for Temasek and TPG declined to comment.","news_type":1},"isVote":1,"tweetType":1,"viewCount":495,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":128593921,"gmtCreate":1624522332963,"gmtModify":1703839213688,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/V\">$Visa(V)$</a>[Miser]&nbsp;","listText":"<a href=\"https://laohu8.com/S/V\">$Visa(V)$</a>[Miser]&nbsp;","text":"$Visa(V)$[Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/128593921","isVote":1,"tweetType":1,"viewCount":369,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129441822,"gmtCreate":1624383833766,"gmtModify":1703835213613,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"Good day for S&amp;P","listText":"Good day for S&amp;P","text":"Good day for S&P","images":[{"img":"https://static.tigerbbs.com/e23d2dc900bb1fd5478aa91677df3d3c","width":"1125","height":"3461"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129441822","isVote":1,"tweetType":1,"viewCount":382,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":129443804,"gmtCreate":1624383693508,"gmtModify":1703835212472,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>[Surprised]&nbsp;[Surprised]&nbsp;[Surprised]&nbsp;","listText":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>[Surprised]&nbsp;[Surprised]&nbsp;[Surprised]&nbsp;","text":"$Moderna, Inc.(MRNA)$[Surprised] [Surprised] [Surprised]","images":[{"img":"https://static.tigerbbs.com/91ae1ea94b340ec39e5a395c2a145af3","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129443804","isVote":1,"tweetType":1,"viewCount":148,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":167795333,"gmtCreate":1624284133722,"gmtModify":1703832446519,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"Just a passing storm!","listText":"Just a passing storm!","text":"Just a passing storm!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/167795333","repostId":"1171968125","repostType":4,"repost":{"id":"1171968125","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624282019,"share":"https://ttm.financial/m/news/1171968125?lang=&edition=fundamental","pubTime":"2021-06-21 21:26","market":"us","language":"en","title":"Dow jumps more than 200 points, rebounds from its worst week since October","url":"https://stock-news.laohu8.com/highlight/detail?id=1171968125","media":"Tiger Newspress","summary":"(June 21) U.S. stocks climbed on Monday as the market attempted to rebound from the Dow Jones Indust","content":"<p>(June 21)&nbsp;U.S. stocks climbed on Monday as the market attempted to rebound from the Dow Jones Industrial average's worst week since October.</p>\n<p>The blue-chip Dow rose 220 points, while the S&amp;P 500 gained 0.3%. The tech-heavy Nasdaq Composite traded near the flatline.</p>\n<p>Commodity stocks that were hit hard last week were rebounding, including Exxon and Chevron up about 1% apiece. Reopening plays including Royal Caribbean and Boeing were slightly higher. Banks including JPMorgan, Bank of America and Goldman Sachs also rebounded.</p>\n<p>U.S. stocks fell last week as investors digested new economic projections from the Federal Reserve and worried rate hikes could come sooner than expected. The Fed on Wednesdayraised its inflation expectations and forecast rate hikes in 2023. St. Louis Fed President Jim BullardsaidFriday on CNBC's&nbsp;\"Squawk Box\"that it was natural for the central bank to tilt a little more \"hawkish\" and saw higher interest rates as soon as 2022.</p>\n<p>\"The Fed's 'surprise' move toward tapering that took markets lower last week is just the moment of recognition for a tightening trend that began months ago,\" Mike Wilson, chief U.S. equity strategist, said in a note. \"When combined with the peak rate of change in economic and earnings revisions, it sets up a more difficult summer.\"</p>\n<p>The Dow dropped 3.5% last week, while the S&amp;P 500 and Nasdaq dipped 1.9% and 0.2%, respectively, on the week.</p>\n<p>The U.S. market on Monday was resilient in the face of an overnight drop in Asian markets and a big decline in bitcoin. Japan'sNikkei 225 fell as muchas 4% at one point on Monday with automakers Nissan and Honda leading the way. It would end up closing about 3% lower.</p>\n<p>Meanwhile, bitcoinfell more than 6% to $33,000as China continued its crackdown on cryptocurrency mining.</p>\n<p>Sectors tied to the economic recovery led last week's dip in stocks. The S&amp;P 500 financials and materials sectors lost more than 6% on the week, while energy fell more than 5% and industrials dropped more than 3%.</p>\n<p>Those sectors looked set to rebound Monday. The Financial Select Sector SPDR Fund was rebounding by 0.3% in premarket trading. The Materials Select Sector SPDR Fund was higher by 0.6%.</p>\n<p>The Treasury yield curve flattened last week, hitting banks and sending a signal of a potential economic slowdown. The yields of shorter-term Treasurys, like the 2-year note, rose — reflecting expectations of the Fed raising rates. Longer-term yields, like the 10-year note, retreated — a sign of less optimism toward economic growth.</p>\n<p>Investors await public appearances from Fed members on Monday. Bullard and Dallas Fed President Robert Kaplan are set to speak virtually on a Official Monetary and Financial Institutions Forum panel at 9:00 a.m. ET. New York Fed President John Williams is expected to deliver remarks at a Midsize Bank Coalition of America event Monday afternoon.</p>\n<p>Blockchain&nbsp;stocks&nbsp;fell.</p>\n<p><img src=\"https://static.tigerbbs.com/721381ed3fffc8fb65784c8662c2e5bd\" tg-width=\"312\" tg-height=\"325\" referrerpolicy=\"no-referrer\"></p>\n<p>Big&nbsp;tech&nbsp;stocks&nbsp;fell.</p>\n<p><img src=\"https://static.tigerbbs.com/414a6810bde91ea4d477f0a6190fbb08\" tg-width=\"308\" tg-height=\"323\" referrerpolicy=\"no-referrer\"></p>\n<p>Bank&nbsp;stocks&nbsp;rally.</p>\n<p><img src=\"https://static.tigerbbs.com/3d0aa47ccb01c822ed35519fa4aaf6b0\" tg-width=\"312\" tg-height=\"442\" referrerpolicy=\"no-referrer\"></p>\n<p></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow jumps more than 200 points, rebounds from its worst week since October</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow jumps more than 200 points, rebounds from its worst week since October\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-21 21:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(June 21)&nbsp;U.S. stocks climbed on Monday as the market attempted to rebound from the Dow Jones Industrial average's worst week since October.</p>\n<p>The blue-chip Dow rose 220 points, while the S&amp;P 500 gained 0.3%. The tech-heavy Nasdaq Composite traded near the flatline.</p>\n<p>Commodity stocks that were hit hard last week were rebounding, including Exxon and Chevron up about 1% apiece. Reopening plays including Royal Caribbean and Boeing were slightly higher. Banks including JPMorgan, Bank of America and Goldman Sachs also rebounded.</p>\n<p>U.S. stocks fell last week as investors digested new economic projections from the Federal Reserve and worried rate hikes could come sooner than expected. The Fed on Wednesdayraised its inflation expectations and forecast rate hikes in 2023. St. Louis Fed President Jim BullardsaidFriday on CNBC's&nbsp;\"Squawk Box\"that it was natural for the central bank to tilt a little more \"hawkish\" and saw higher interest rates as soon as 2022.</p>\n<p>\"The Fed's 'surprise' move toward tapering that took markets lower last week is just the moment of recognition for a tightening trend that began months ago,\" Mike Wilson, chief U.S. equity strategist, said in a note. \"When combined with the peak rate of change in economic and earnings revisions, it sets up a more difficult summer.\"</p>\n<p>The Dow dropped 3.5% last week, while the S&amp;P 500 and Nasdaq dipped 1.9% and 0.2%, respectively, on the week.</p>\n<p>The U.S. market on Monday was resilient in the face of an overnight drop in Asian markets and a big decline in bitcoin. Japan'sNikkei 225 fell as muchas 4% at one point on Monday with automakers Nissan and Honda leading the way. It would end up closing about 3% lower.</p>\n<p>Meanwhile, bitcoinfell more than 6% to $33,000as China continued its crackdown on cryptocurrency mining.</p>\n<p>Sectors tied to the economic recovery led last week's dip in stocks. The S&amp;P 500 financials and materials sectors lost more than 6% on the week, while energy fell more than 5% and industrials dropped more than 3%.</p>\n<p>Those sectors looked set to rebound Monday. The Financial Select Sector SPDR Fund was rebounding by 0.3% in premarket trading. The Materials Select Sector SPDR Fund was higher by 0.6%.</p>\n<p>The Treasury yield curve flattened last week, hitting banks and sending a signal of a potential economic slowdown. The yields of shorter-term Treasurys, like the 2-year note, rose — reflecting expectations of the Fed raising rates. Longer-term yields, like the 10-year note, retreated — a sign of less optimism toward economic growth.</p>\n<p>Investors await public appearances from Fed members on Monday. Bullard and Dallas Fed President Robert Kaplan are set to speak virtually on a Official Monetary and Financial Institutions Forum panel at 9:00 a.m. ET. New York Fed President John Williams is expected to deliver remarks at a Midsize Bank Coalition of America event Monday afternoon.</p>\n<p>Blockchain&nbsp;stocks&nbsp;fell.</p>\n<p><img src=\"https://static.tigerbbs.com/721381ed3fffc8fb65784c8662c2e5bd\" tg-width=\"312\" tg-height=\"325\" referrerpolicy=\"no-referrer\"></p>\n<p>Big&nbsp;tech&nbsp;stocks&nbsp;fell.</p>\n<p><img src=\"https://static.tigerbbs.com/414a6810bde91ea4d477f0a6190fbb08\" tg-width=\"308\" tg-height=\"323\" referrerpolicy=\"no-referrer\"></p>\n<p>Bank&nbsp;stocks&nbsp;rally.</p>\n<p><img src=\"https://static.tigerbbs.com/3d0aa47ccb01c822ed35519fa4aaf6b0\" tg-width=\"312\" tg-height=\"442\" referrerpolicy=\"no-referrer\"></p>\n<p></p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index","SPY":"标普500ETF",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171968125","content_text":"(June 21) U.S. stocks climbed on Monday as the market attempted to rebound from the Dow Jones Industrial average's worst week since October.\nThe blue-chip Dow rose 220 points, while the S&P 500 gained 0.3%. The tech-heavy Nasdaq Composite traded near the flatline.\nCommodity stocks that were hit hard last week were rebounding, including Exxon and Chevron up about 1% apiece. Reopening plays including Royal Caribbean and Boeing were slightly higher. Banks including JPMorgan, Bank of America and Goldman Sachs also rebounded.\nU.S. stocks fell last week as investors digested new economic projections from the Federal Reserve and worried rate hikes could come sooner than expected. The Fed on Wednesdayraised its inflation expectations and forecast rate hikes in 2023. St. Louis Fed President Jim BullardsaidFriday on CNBC's \"Squawk Box\"that it was natural for the central bank to tilt a little more \"hawkish\" and saw higher interest rates as soon as 2022.\n\"The Fed's 'surprise' move toward tapering that took markets lower last week is just the moment of recognition for a tightening trend that began months ago,\" Mike Wilson, chief U.S. equity strategist, said in a note. \"When combined with the peak rate of change in economic and earnings revisions, it sets up a more difficult summer.\"\nThe Dow dropped 3.5% last week, while the S&P 500 and Nasdaq dipped 1.9% and 0.2%, respectively, on the week.\nThe U.S. market on Monday was resilient in the face of an overnight drop in Asian markets and a big decline in bitcoin. Japan'sNikkei 225 fell as muchas 4% at one point on Monday with automakers Nissan and Honda leading the way. It would end up closing about 3% lower.\nMeanwhile, bitcoinfell more than 6% to $33,000as China continued its crackdown on cryptocurrency mining.\nSectors tied to the economic recovery led last week's dip in stocks. The S&P 500 financials and materials sectors lost more than 6% on the week, while energy fell more than 5% and industrials dropped more than 3%.\nThose sectors looked set to rebound Monday. The Financial Select Sector SPDR Fund was rebounding by 0.3% in premarket trading. The Materials Select Sector SPDR Fund was higher by 0.6%.\nThe Treasury yield curve flattened last week, hitting banks and sending a signal of a potential economic slowdown. The yields of shorter-term Treasurys, like the 2-year note, rose — reflecting expectations of the Fed raising rates. Longer-term yields, like the 10-year note, retreated — a sign of less optimism toward economic growth.\nInvestors await public appearances from Fed members on Monday. Bullard and Dallas Fed President Robert Kaplan are set to speak virtually on a Official Monetary and Financial Institutions Forum panel at 9:00 a.m. ET. New York Fed President John Williams is expected to deliver remarks at a Midsize Bank Coalition of America event Monday afternoon.\nBlockchain stocks fell.\n\nBig tech stocks fell.\n\nBank stocks rally.","news_type":1},"isVote":1,"tweetType":1,"viewCount":100,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":167796481,"gmtCreate":1624284096743,"gmtModify":1703832445030,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PYPL\">$PayPal(PYPL)$</a>To greater heights!","listText":"<a href=\"https://laohu8.com/S/PYPL\">$PayPal(PYPL)$</a>To greater heights!","text":"$PayPal(PYPL)$To greater heights!","images":[{"img":"https://static.tigerbbs.com/1a3ff9e9129413d22b7bcda883f77356","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/167796481","isVote":1,"tweetType":1,"viewCount":116,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":167445740,"gmtCreate":1624283377880,"gmtModify":1703832404464,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"To greater heights! [Miser]&nbsp;","listText":"To greater heights! [Miser]&nbsp;","text":"To greater heights! [Miser]","images":[{"img":"https://static.tigerbbs.com/f05b2957592e34ac0a60afae3b707932","width":"1125","height":"3372"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/167445740","isVote":1,"tweetType":1,"viewCount":258,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":167457417,"gmtCreate":1624283245639,"gmtModify":1703832392927,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"[Cry]&nbsp;","listText":"[Cry]&nbsp;","text":"[Cry]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/167457417","repostId":"1154249454","repostType":4,"repost":{"id":"1154249454","kind":"news","pubTimestamp":1624230573,"share":"https://ttm.financial/m/news/1154249454?lang=&edition=fundamental","pubTime":"2021-06-21 07:09","market":"us","language":"en","title":"Nike, FedEx, Johnson & Johnson, Darden, and Other Stocks for Investors to Watch This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1154249454","media":"barrons","summary":"A handful of notable companies will release their latest results toward the end of this week.Nike,FedEx,andDarden Restaurantswill report on Thursday, followed by CarMax and Paychex on Friday. Wednesday will also feature analyst days and investor events from Johnson & Johnson, GlaxoSmithKline,and Equinix.Economic data out this week include IHS’ Manufacturing and Services Purchasing Managers’ Indexes for June on Wednesday. Both are expected to hold near their record highs. The Census Bureau will r","content":"<p>A handful of notable companies will release their latest results toward the end of this week.Nike,FedEx,andDarden Restaurantswill report on Thursday, followed by CarMax and Paychex on Friday. Wednesday will also feature analyst days and investor events from&nbsp;Johnson &amp;&nbsp;Johnson,&nbsp;GlaxoSmithKline,and&nbsp;Equinix.</p>\n<p>Economic data out this week include IHS’ Manufacturing and Services Purchasing Managers’ Indexes for June on Wednesday. Both are expected to hold near their record highs. The Census Bureau will release the durable-goods report for May on Thursday. Orders—often seen as a decent proxy for business investment—are expected to rise 3.3% month over month.</p>\n<p>And on Friday, the Bureau of Economic Analysis will report personal income and consumption for May. Spending is forecast to continue rising despite a drop off in income as stimulus checks finished being sent out in April.</p>\n<p>Monday 6/21</p>\n<p><b>The Federal Reserve Bank</b>of Chicago releases its National Activity index, a gauge of overall economic activity, for May. Expectations are for a 0.50 reading, higher than April’s 0.24 figure. A positive reading indicates economic growth that is above historical trends.</p>\n<p>Tuesday 6/22</p>\n<p><b>The National Association</b>of Realtors reports existing-home sales for May. Economists forecast a seasonally adjusted annual rate of 5.7 million homes sold, about 150,000 fewer than the April data. Existing-home sales have fallen for three consecutive months, as supply hasn’t been able to keep up with demand.</p>\n<p>Wednesday 6/23</p>\n<p>Equinix hosts its 2021 analyst day, when the company will update its long-term financial outlook.</p>\n<p>GlaxoSmithKline hosts a conference call, featuring its CEO, Emma Walmsley, to update investors on the company’s strategy for growth and shareholder value creation.</p>\n<p>Johnson &amp; Johnson hosts a webcast to discuss its ESG strategy.</p>\n<p><b>The Census Bureau</b>reports new residential construction data for May. Consensus estimate is for a seasonally adjusted annual rate of 875,000 new single-family homes sold, slightly higher than April’s 863,000. Similar to existing-home sales, new-home sales have fallen from their recent peak of 993,000 in January of this year.</p>\n<p><b>IHS Markitreports</b>both its Manufacturing and Services Purchasing Managers’ indexes for June. Expectations are for a 61.5 reading for the Manufacturing PMI, and a 69.8 figure for the Services PMI. Both projections are comparable to the May data as well as being near record highs for their respective indexes.</p>\n<p>Thursday 6/24</p>\n<p><b>The Bureau of Economic Analysis</b>reports the third and final estimate of first-quarter gross-domestic-product growth. Economists forecast a seasonally adjusted annual growth rate of 6.4%.</p>\n<p>Accenture,Darden Restaurants, FedEx, and Nike hold conference calls to discuss quarterly results.</p>\n<p><b>The Bank of England</b>announces its monetary-policy decision. The central bank is widely expected to keep its key interest rate at 0.1%.</p>\n<p><b>The Census Bureau</b>releases the durable-goods report for May. The consensus call is for new orders of manufactured goods to rise 2.8% month over month to $253 billion. Excluding transportation, new orders are projected at 1%, matching the April data.</p>\n<p>Friday 6/25</p>\n<p>CarMax and Paychex report earnings.</p>\n<p><b>The BEA reports</b>personal income and consumption for May. Income is expected to fall 3% month over month, after plummeting 13.1% in April. This reflects a dropoff in stimulus checks that first were sent out in March. Spending is seen rising 0.5%, comparable to the April data.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nike, FedEx, Johnson & Johnson, Darden, and Other Stocks for Investors to Watch This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNike, FedEx, Johnson & Johnson, Darden, and Other Stocks for Investors to Watch This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-21 07:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/nike-fedex-johnson-johnson-darden-and-other-stocks-for-investors-to-watch-this-week-51624215603?mod=hp_LEAD_3><strong>barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A handful of notable companies will release their latest results toward the end of this week.Nike,FedEx,andDarden Restaurantswill report on Thursday, followed by CarMax and Paychex on Friday. ...</p>\n\n<a href=\"https://www.barrons.com/articles/nike-fedex-johnson-johnson-darden-and-other-stocks-for-investors-to-watch-this-week-51624215603?mod=hp_LEAD_3\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","NKE":"耐克","DRI":"达登饭店","FDX":"联邦快递"},"source_url":"https://www.barrons.com/articles/nike-fedex-johnson-johnson-darden-and-other-stocks-for-investors-to-watch-this-week-51624215603?mod=hp_LEAD_3","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154249454","content_text":"A handful of notable companies will release their latest results toward the end of this week.Nike,FedEx,andDarden Restaurantswill report on Thursday, followed by CarMax and Paychex on Friday. Wednesday will also feature analyst days and investor events from Johnson & Johnson, GlaxoSmithKline,and Equinix.\nEconomic data out this week include IHS’ Manufacturing and Services Purchasing Managers’ Indexes for June on Wednesday. Both are expected to hold near their record highs. The Census Bureau will release the durable-goods report for May on Thursday. Orders—often seen as a decent proxy for business investment—are expected to rise 3.3% month over month.\nAnd on Friday, the Bureau of Economic Analysis will report personal income and consumption for May. Spending is forecast to continue rising despite a drop off in income as stimulus checks finished being sent out in April.\nMonday 6/21\nThe Federal Reserve Bankof Chicago releases its National Activity index, a gauge of overall economic activity, for May. Expectations are for a 0.50 reading, higher than April’s 0.24 figure. A positive reading indicates economic growth that is above historical trends.\nTuesday 6/22\nThe National Associationof Realtors reports existing-home sales for May. Economists forecast a seasonally adjusted annual rate of 5.7 million homes sold, about 150,000 fewer than the April data. Existing-home sales have fallen for three consecutive months, as supply hasn’t been able to keep up with demand.\nWednesday 6/23\nEquinix hosts its 2021 analyst day, when the company will update its long-term financial outlook.\nGlaxoSmithKline hosts a conference call, featuring its CEO, Emma Walmsley, to update investors on the company’s strategy for growth and shareholder value creation.\nJohnson & Johnson hosts a webcast to discuss its ESG strategy.\nThe Census Bureaureports new residential construction data for May. Consensus estimate is for a seasonally adjusted annual rate of 875,000 new single-family homes sold, slightly higher than April’s 863,000. Similar to existing-home sales, new-home sales have fallen from their recent peak of 993,000 in January of this year.\nIHS Markitreportsboth its Manufacturing and Services Purchasing Managers’ indexes for June. Expectations are for a 61.5 reading for the Manufacturing PMI, and a 69.8 figure for the Services PMI. Both projections are comparable to the May data as well as being near record highs for their respective indexes.\nThursday 6/24\nThe Bureau of Economic Analysisreports the third and final estimate of first-quarter gross-domestic-product growth. Economists forecast a seasonally adjusted annual growth rate of 6.4%.\nAccenture,Darden Restaurants, FedEx, and Nike hold conference calls to discuss quarterly results.\nThe Bank of Englandannounces its monetary-policy decision. The central bank is widely expected to keep its key interest rate at 0.1%.\nThe Census Bureaureleases the durable-goods report for May. The consensus call is for new orders of manufactured goods to rise 2.8% month over month to $253 billion. Excluding transportation, new orders are projected at 1%, matching the April data.\nFriday 6/25\nCarMax and Paychex report earnings.\nThe BEA reportspersonal income and consumption for May. Income is expected to fall 3% month over month, after plummeting 13.1% in April. This reflects a dropoff in stimulus checks that first were sent out in March. Spending is seen rising 0.5%, comparable to the April data.","news_type":1},"isVote":1,"tweetType":1,"viewCount":105,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":162939114,"gmtCreate":1624030518138,"gmtModify":1703827186550,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MTCH\">$Match(MTCH)$</a>up!","listText":"<a href=\"https://laohu8.com/S/MTCH\">$Match(MTCH)$</a>up!","text":"$Match(MTCH)$up!","images":[{"img":"https://static.tigerbbs.com/99cd573dea84efb2571133ca8ad0a986","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/162939114","isVote":1,"tweetType":1,"viewCount":47,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":169417744,"gmtCreate":1623847289288,"gmtModify":1703821226035,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RBLX\">$Roblox Corporation(RBLX)$</a>=(=(=(","listText":"<a href=\"https://laohu8.com/S/RBLX\">$Roblox Corporation(RBLX)$</a>=(=(=(","text":"$Roblox Corporation(RBLX)$=(=(=(","images":[{"img":"https://static.tigerbbs.com/a4d1b1e12e5caed6244a1570207ae59e","width":"1125","height":"2183"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/169417744","isVote":1,"tweetType":1,"viewCount":226,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":184399313,"gmtCreate":1623683152532,"gmtModify":1704208668653,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"Is it time to buy the dip?","listText":"Is it time to buy the dip?","text":"Is it time to buy the dip?","images":[{"img":"https://static.tigerbbs.com/330ce11cec8e02a0e2af20d296444c70","width":"1125","height":"3462"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/184399313","isVote":1,"tweetType":1,"viewCount":166,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":131246060,"gmtCreate":1621864956850,"gmtModify":1704363521661,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IDXX\">$IDEXX Laboratories(IDXX)$</a>=)","listText":"<a href=\"https://laohu8.com/S/IDXX\">$IDEXX Laboratories(IDXX)$</a>=)","text":"$IDEXX Laboratories(IDXX)$=)","images":[{"img":"https://static.tigerbbs.com/02dea9d4fadad029b48718f4e0794171","width":"1125","height":"2183"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/131246060","isVote":1,"tweetType":1,"viewCount":122,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"hots":[{"id":833136071,"gmtCreate":1629209536393,"gmtModify":1676529967325,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"??&nbsp;","listText":"??&nbsp;","text":"??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/833136071","repostId":"1115558959","repostType":4,"isVote":1,"tweetType":1,"viewCount":445,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":156544825,"gmtCreate":1625232759967,"gmtModify":1703738963658,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"[Surprised]&nbsp;","listText":"[Surprised]&nbsp;","text":"[Surprised]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/156544825","repostId":"1126312436","repostType":4,"repost":{"id":"1126312436","kind":"news","pubTimestamp":1625212145,"share":"https://ttm.financial/m/news/1126312436?lang=&edition=fundamental","pubTime":"2021-07-02 15:49","market":"us","language":"en","title":"The Stock Market Had a Great First Half. 3 Things That Could Cause it to Crash.","url":"https://stock-news.laohu8.com/highlight/detail?id=1126312436","media":"Barrons","summary":"Stocks have soared relentlessly this year. Several factors, however, have the potential to end the p","content":"<p>Stocks have soared relentlessly this year. Several factors, however, have the potential to end the party.</p>\n<p>The S&amp;P 500 has had its second-best first half of a year since 1998, and it hasn’t shown many signs of letting up. The index ended June up 14.4% year to date, hitting several records during the month and posting another record close on Thursday.</p>\n<p>Yet there are a couple key risks that could turn all of that around, according to Nick Colas, co-founder of DataTrek.</p>\n<p>First, there’s the possibility of an oil price shock, as the price of crude has shown little sign of cooling off. WTI crude oil is up 56% year to date and notched a&nbsp;new multi-year high&nbsp;Thursday—even amid growing&nbsp;expectations that OPEC will increase supply. If oil prices run hot enough, that could raise inflation to a level that—if sustained — could cause consumer demand to fall and that could surpass Federal Reserve expectations.</p>\n<p>“Suddenly higher oil prices” is atop the list of stock market concerns for Colas. “Rapidly rising oil prices will cause U.S. inflation to overshoot the Fed’s desired outcome and also stress the American consumer.”</p>\n<p>Both those things could dent the stock market, which has long benefited from the Fed’s accommodative monetary policy, especially if the Fed signals that interest-rate increases could come sooner than expected.</p>\n<p>That means the Fed will need to tread carefully when discussing rates to avoid spooking the market, Colas says.</p>\n<p>“Federal Reserve miscommunication about upcoming policy changes and/or raising interest rates too aggressively” is a second risk, Colas says. For instance, the S&amp;P 500&nbsp;dived 18% over roughly three months in late 2018 as the Fed raised rates, despite the market’s hope at that time for rates to stay put.</p>\n<p>Peaking earnings growth is the other threat to stocks, Colas says. Earnings growth for the average S&amp;P 500 company is expected slow down to 11% in 2022 from 36% in 2021, according to FactSet, as the economy normalizes and the postpandemic recovery eases. But on average, S&amp;P 500 stocks trade at 21.5 times expected earnings for the next 12 months, still above the index’s pre-pandemic multiple. At some point, stocks valuations will need to better reflect the expected decline in earnings growth, which would mean falling stock prices.</p>\n<p>“Valuations are high enough currently that peaking earnings could be a larger risk than before,” Colas writes.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Stock Market Had a Great First Half. 3 Things That Could Cause it to Crash.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Stock Market Had a Great First Half. 3 Things That Could Cause it to Crash.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-02 15:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/stock-market-crash-risks-51625174065><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stocks have soared relentlessly this year. Several factors, however, have the potential to end the party.\nThe S&P 500 has had its second-best first half of a year since 1998, and it hasn’t shown many ...</p>\n\n<a href=\"https://www.barrons.com/articles/stock-market-crash-risks-51625174065\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"https://www.barrons.com/articles/stock-market-crash-risks-51625174065","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1126312436","content_text":"Stocks have soared relentlessly this year. Several factors, however, have the potential to end the party.\nThe S&P 500 has had its second-best first half of a year since 1998, and it hasn’t shown many signs of letting up. The index ended June up 14.4% year to date, hitting several records during the month and posting another record close on Thursday.\nYet there are a couple key risks that could turn all of that around, according to Nick Colas, co-founder of DataTrek.\nFirst, there’s the possibility of an oil price shock, as the price of crude has shown little sign of cooling off. WTI crude oil is up 56% year to date and notched a new multi-year high Thursday—even amid growing expectations that OPEC will increase supply. If oil prices run hot enough, that could raise inflation to a level that—if sustained — could cause consumer demand to fall and that could surpass Federal Reserve expectations.\n“Suddenly higher oil prices” is atop the list of stock market concerns for Colas. “Rapidly rising oil prices will cause U.S. inflation to overshoot the Fed’s desired outcome and also stress the American consumer.”\nBoth those things could dent the stock market, which has long benefited from the Fed’s accommodative monetary policy, especially if the Fed signals that interest-rate increases could come sooner than expected.\nThat means the Fed will need to tread carefully when discussing rates to avoid spooking the market, Colas says.\n“Federal Reserve miscommunication about upcoming policy changes and/or raising interest rates too aggressively” is a second risk, Colas says. For instance, the S&P 500 dived 18% over roughly three months in late 2018 as the Fed raised rates, despite the market’s hope at that time for rates to stay put.\nPeaking earnings growth is the other threat to stocks, Colas says. Earnings growth for the average S&P 500 company is expected slow down to 11% in 2022 from 36% in 2021, according to FactSet, as the economy normalizes and the postpandemic recovery eases. But on average, S&P 500 stocks trade at 21.5 times expected earnings for the next 12 months, still above the index’s pre-pandemic multiple. At some point, stocks valuations will need to better reflect the expected decline in earnings growth, which would mean falling stock prices.\n“Valuations are high enough currently that peaking earnings could be a larger risk than before,” Colas writes.","news_type":1},"isVote":1,"tweetType":1,"viewCount":195,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":167457417,"gmtCreate":1624283245639,"gmtModify":1703832392927,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"[Cry]&nbsp;","listText":"[Cry]&nbsp;","text":"[Cry]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/167457417","repostId":"1154249454","repostType":4,"repost":{"id":"1154249454","kind":"news","pubTimestamp":1624230573,"share":"https://ttm.financial/m/news/1154249454?lang=&edition=fundamental","pubTime":"2021-06-21 07:09","market":"us","language":"en","title":"Nike, FedEx, Johnson & Johnson, Darden, and Other Stocks for Investors to Watch This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1154249454","media":"barrons","summary":"A handful of notable companies will release their latest results toward the end of this week.Nike,FedEx,andDarden Restaurantswill report on Thursday, followed by CarMax and Paychex on Friday. Wednesday will also feature analyst days and investor events from Johnson & Johnson, GlaxoSmithKline,and Equinix.Economic data out this week include IHS’ Manufacturing and Services Purchasing Managers’ Indexes for June on Wednesday. Both are expected to hold near their record highs. The Census Bureau will r","content":"<p>A handful of notable companies will release their latest results toward the end of this week.Nike,FedEx,andDarden Restaurantswill report on Thursday, followed by CarMax and Paychex on Friday. Wednesday will also feature analyst days and investor events from&nbsp;Johnson &amp;&nbsp;Johnson,&nbsp;GlaxoSmithKline,and&nbsp;Equinix.</p>\n<p>Economic data out this week include IHS’ Manufacturing and Services Purchasing Managers’ Indexes for June on Wednesday. Both are expected to hold near their record highs. The Census Bureau will release the durable-goods report for May on Thursday. Orders—often seen as a decent proxy for business investment—are expected to rise 3.3% month over month.</p>\n<p>And on Friday, the Bureau of Economic Analysis will report personal income and consumption for May. Spending is forecast to continue rising despite a drop off in income as stimulus checks finished being sent out in April.</p>\n<p>Monday 6/21</p>\n<p><b>The Federal Reserve Bank</b>of Chicago releases its National Activity index, a gauge of overall economic activity, for May. Expectations are for a 0.50 reading, higher than April’s 0.24 figure. A positive reading indicates economic growth that is above historical trends.</p>\n<p>Tuesday 6/22</p>\n<p><b>The National Association</b>of Realtors reports existing-home sales for May. Economists forecast a seasonally adjusted annual rate of 5.7 million homes sold, about 150,000 fewer than the April data. Existing-home sales have fallen for three consecutive months, as supply hasn’t been able to keep up with demand.</p>\n<p>Wednesday 6/23</p>\n<p>Equinix hosts its 2021 analyst day, when the company will update its long-term financial outlook.</p>\n<p>GlaxoSmithKline hosts a conference call, featuring its CEO, Emma Walmsley, to update investors on the company’s strategy for growth and shareholder value creation.</p>\n<p>Johnson &amp; Johnson hosts a webcast to discuss its ESG strategy.</p>\n<p><b>The Census Bureau</b>reports new residential construction data for May. Consensus estimate is for a seasonally adjusted annual rate of 875,000 new single-family homes sold, slightly higher than April’s 863,000. Similar to existing-home sales, new-home sales have fallen from their recent peak of 993,000 in January of this year.</p>\n<p><b>IHS Markitreports</b>both its Manufacturing and Services Purchasing Managers’ indexes for June. Expectations are for a 61.5 reading for the Manufacturing PMI, and a 69.8 figure for the Services PMI. Both projections are comparable to the May data as well as being near record highs for their respective indexes.</p>\n<p>Thursday 6/24</p>\n<p><b>The Bureau of Economic Analysis</b>reports the third and final estimate of first-quarter gross-domestic-product growth. Economists forecast a seasonally adjusted annual growth rate of 6.4%.</p>\n<p>Accenture,Darden Restaurants, FedEx, and Nike hold conference calls to discuss quarterly results.</p>\n<p><b>The Bank of England</b>announces its monetary-policy decision. The central bank is widely expected to keep its key interest rate at 0.1%.</p>\n<p><b>The Census Bureau</b>releases the durable-goods report for May. The consensus call is for new orders of manufactured goods to rise 2.8% month over month to $253 billion. Excluding transportation, new orders are projected at 1%, matching the April data.</p>\n<p>Friday 6/25</p>\n<p>CarMax and Paychex report earnings.</p>\n<p><b>The BEA reports</b>personal income and consumption for May. Income is expected to fall 3% month over month, after plummeting 13.1% in April. This reflects a dropoff in stimulus checks that first were sent out in March. Spending is seen rising 0.5%, comparable to the April data.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nike, FedEx, Johnson & Johnson, Darden, and Other Stocks for Investors to Watch This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNike, FedEx, Johnson & Johnson, Darden, and Other Stocks for Investors to Watch This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-21 07:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/nike-fedex-johnson-johnson-darden-and-other-stocks-for-investors-to-watch-this-week-51624215603?mod=hp_LEAD_3><strong>barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A handful of notable companies will release their latest results toward the end of this week.Nike,FedEx,andDarden Restaurantswill report on Thursday, followed by CarMax and Paychex on Friday. ...</p>\n\n<a href=\"https://www.barrons.com/articles/nike-fedex-johnson-johnson-darden-and-other-stocks-for-investors-to-watch-this-week-51624215603?mod=hp_LEAD_3\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","NKE":"耐克","DRI":"达登饭店","FDX":"联邦快递"},"source_url":"https://www.barrons.com/articles/nike-fedex-johnson-johnson-darden-and-other-stocks-for-investors-to-watch-this-week-51624215603?mod=hp_LEAD_3","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154249454","content_text":"A handful of notable companies will release their latest results toward the end of this week.Nike,FedEx,andDarden Restaurantswill report on Thursday, followed by CarMax and Paychex on Friday. Wednesday will also feature analyst days and investor events from Johnson & Johnson, GlaxoSmithKline,and Equinix.\nEconomic data out this week include IHS’ Manufacturing and Services Purchasing Managers’ Indexes for June on Wednesday. Both are expected to hold near their record highs. The Census Bureau will release the durable-goods report for May on Thursday. Orders—often seen as a decent proxy for business investment—are expected to rise 3.3% month over month.\nAnd on Friday, the Bureau of Economic Analysis will report personal income and consumption for May. Spending is forecast to continue rising despite a drop off in income as stimulus checks finished being sent out in April.\nMonday 6/21\nThe Federal Reserve Bankof Chicago releases its National Activity index, a gauge of overall economic activity, for May. Expectations are for a 0.50 reading, higher than April’s 0.24 figure. A positive reading indicates economic growth that is above historical trends.\nTuesday 6/22\nThe National Associationof Realtors reports existing-home sales for May. Economists forecast a seasonally adjusted annual rate of 5.7 million homes sold, about 150,000 fewer than the April data. Existing-home sales have fallen for three consecutive months, as supply hasn’t been able to keep up with demand.\nWednesday 6/23\nEquinix hosts its 2021 analyst day, when the company will update its long-term financial outlook.\nGlaxoSmithKline hosts a conference call, featuring its CEO, Emma Walmsley, to update investors on the company’s strategy for growth and shareholder value creation.\nJohnson & Johnson hosts a webcast to discuss its ESG strategy.\nThe Census Bureaureports new residential construction data for May. Consensus estimate is for a seasonally adjusted annual rate of 875,000 new single-family homes sold, slightly higher than April’s 863,000. Similar to existing-home sales, new-home sales have fallen from their recent peak of 993,000 in January of this year.\nIHS Markitreportsboth its Manufacturing and Services Purchasing Managers’ indexes for June. Expectations are for a 61.5 reading for the Manufacturing PMI, and a 69.8 figure for the Services PMI. Both projections are comparable to the May data as well as being near record highs for their respective indexes.\nThursday 6/24\nThe Bureau of Economic Analysisreports the third and final estimate of first-quarter gross-domestic-product growth. Economists forecast a seasonally adjusted annual growth rate of 6.4%.\nAccenture,Darden Restaurants, FedEx, and Nike hold conference calls to discuss quarterly results.\nThe Bank of Englandannounces its monetary-policy decision. The central bank is widely expected to keep its key interest rate at 0.1%.\nThe Census Bureaureleases the durable-goods report for May. The consensus call is for new orders of manufactured goods to rise 2.8% month over month to $253 billion. Excluding transportation, new orders are projected at 1%, matching the April data.\nFriday 6/25\nCarMax and Paychex report earnings.\nThe BEA reportspersonal income and consumption for May. Income is expected to fall 3% month over month, after plummeting 13.1% in April. This reflects a dropoff in stimulus checks that first were sent out in March. Spending is seen rising 0.5%, comparable to the April data.","news_type":1},"isVote":1,"tweetType":1,"viewCount":105,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":890373633,"gmtCreate":1628085221622,"gmtModify":1703500942624,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NVAX\">$Novavax(NVAX)$</a>to the moon!","listText":"<a href=\"https://laohu8.com/S/NVAX\">$Novavax(NVAX)$</a>to the moon!","text":"$Novavax(NVAX)$to the moon!","images":[{"img":"https://static.tigerbbs.com/cce04145b5b0ff63db9941caf8f1bb57","width":"1125","height":"2183"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/890373633","isVote":1,"tweetType":1,"viewCount":402,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":128591727,"gmtCreate":1624522398269,"gmtModify":1703839216133,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/128591727","repostId":"1114144195","repostType":4,"repost":{"id":"1114144195","kind":"news","pubTimestamp":1624522045,"share":"https://ttm.financial/m/news/1114144195?lang=&edition=fundamental","pubTime":"2021-06-24 16:07","market":"sg","language":"en","title":"Temasek-backed online pharmacy seeks funds at US$4b valuation: sources","url":"https://stock-news.laohu8.com/highlight/detail?id=1114144195","media":"Bloomberg","summary":"[MAHARASHTRA] API Holdings is weighing a new funding round that could value the owner of India's lar","content":"<p>[MAHARASHTRA] API Holdings is weighing a new funding round that could value the owner of India's largest online pharmacy chain at about US$4 billion, according to people familiar with the matter.</p>\n<p>The company is considering raising about US$300 million and its existing investors including TPG Capital and Temasek Holdings could participate, said the people, who asked not to be identified as the discussions are private.</p>\n<p>API, which owns India's first e-pharmacy unicorn PharmEasy, intends to use the proceeds for potential acquisitions particularly in the diagnostic area, one of the people said.</p>\n<p>A new round would mark the second fundraising by API Holdings within a few months after securing about US$350 million in April. The firm last raised funds from a clutch of investors including Prosus Ventures, TPG and Temasek, according to a press release at that time.</p>\n<p>PharmEasy has so far delivered more than 15 million orders from medicine to diagnostic kits to healthcare products, serving over five million families, according to its website.</p>\n<p>Deliberations are ongoing and details of the fundraising could still change, the people said. Siddharth Shah, API's co-founder and chief executive officer, didn't respond to messages for comment, while representatives for Temasek and TPG declined to comment.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Temasek-backed online pharmacy seeks funds at US$4b valuation: sources</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTemasek-backed online pharmacy seeks funds at US$4b valuation: sources\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 16:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.businesstimes.com.sg/garage/temasek-backed-online-pharmacy-seeks-funds-at-us4b-valuation-sources><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>[MAHARASHTRA] API Holdings is weighing a new funding round that could value the owner of India's largest online pharmacy chain at about US$4 billion, according to people familiar with the matter.\nThe ...</p>\n\n<a href=\"https://www.businesstimes.com.sg/garage/temasek-backed-online-pharmacy-seeks-funds-at-us4b-valuation-sources\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.businesstimes.com.sg/garage/temasek-backed-online-pharmacy-seeks-funds-at-us4b-valuation-sources","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114144195","content_text":"[MAHARASHTRA] API Holdings is weighing a new funding round that could value the owner of India's largest online pharmacy chain at about US$4 billion, according to people familiar with the matter.\nThe company is considering raising about US$300 million and its existing investors including TPG Capital and Temasek Holdings could participate, said the people, who asked not to be identified as the discussions are private.\nAPI, which owns India's first e-pharmacy unicorn PharmEasy, intends to use the proceeds for potential acquisitions particularly in the diagnostic area, one of the people said.\nA new round would mark the second fundraising by API Holdings within a few months after securing about US$350 million in April. The firm last raised funds from a clutch of investors including Prosus Ventures, TPG and Temasek, according to a press release at that time.\nPharmEasy has so far delivered more than 15 million orders from medicine to diagnostic kits to healthcare products, serving over five million families, according to its website.\nDeliberations are ongoing and details of the fundraising could still change, the people said. Siddharth Shah, API's co-founder and chief executive officer, didn't respond to messages for comment, while representatives for Temasek and TPG declined to comment.","news_type":1},"isVote":1,"tweetType":1,"viewCount":495,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":328755295,"gmtCreate":1615561374417,"gmtModify":1704784614700,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FCX\">$Freeport-McMoRan(FCX)$</a>keep going!","listText":"<a href=\"https://laohu8.com/S/FCX\">$Freeport-McMoRan(FCX)$</a>keep going!","text":"$Freeport-McMoRan(FCX)$keep going!","images":[{"img":"https://static.tigerbbs.com/87b885cc2cb4b0425568b6382bdcd391","width":"1125","height":"2183"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/328755295","isVote":1,"tweetType":1,"viewCount":8,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":141117570,"gmtCreate":1625841883290,"gmtModify":1703749724577,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MTCH\">$Match(MTCH)$</a>yay!","listText":"<a href=\"https://laohu8.com/S/MTCH\">$Match(MTCH)$</a>yay!","text":"$Match(MTCH)$yay!","images":[{"img":"https://static.tigerbbs.com/0aee2c6706438205a70646f687086ac4","width":"1125","height":"2183"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/141117570","isVote":1,"tweetType":1,"viewCount":536,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":126920343,"gmtCreate":1624542568182,"gmtModify":1703839849966,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"[Miser]&nbsp;","listText":"[Miser]&nbsp;","text":"[Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/126920343","repostId":"1186095717","repostType":4,"repost":{"id":"1186095717","kind":"news","pubTimestamp":1624538824,"share":"https://ttm.financial/m/news/1186095717?lang=&edition=fundamental","pubTime":"2021-06-24 20:47","market":"us","language":"en","title":"IPO Watch: Bright Health, Monte Rosa, Confluent to Start Trading Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1186095717","media":"The Wall Street Journal","summary":"Bright Health Group will start trading on the NYSE today under the ticker BHG. The company sold shar","content":"<p>Bright Health Group will start trading on the NYSE today under the ticker BHG. The company sold shares in its initial public offering at $18 apiece.</p>\n<p>Monte Rosa Therapeutics Inc. will join the Nasdaq Global Select Market as GLUE after selling shares at $19 each.</p>\n<p>Confluent Inc. will make its debut as CFLT. The company's shares were sold in the IPO for $36 each.</p>\n<p>Miromatrix Medical will make its debut on the Nasdaq as MIRO after selling shares at $9 each.</p>\n<p>Grove Inc. will trade as GRVI after selling its stock in the IPO at $5 apiece.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IPO Watch: Bright Health, Monte Rosa, Confluent to Start Trading Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIPO Watch: Bright Health, Monte Rosa, Confluent to Start Trading Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 20:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/ktmYlQj6UfmkqxIEmORt><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Bright Health Group will start trading on the NYSE today under the ticker BHG. The company sold shares in its initial public offering at $18 apiece.\nMonte Rosa Therapeutics Inc. will join the Nasdaq ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/ktmYlQj6UfmkqxIEmORt\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CFLT":"Confluent, Inc.","GLUE":"Monte Rosa Therapeutics"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/ktmYlQj6UfmkqxIEmORt","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1186095717","content_text":"Bright Health Group will start trading on the NYSE today under the ticker BHG. The company sold shares in its initial public offering at $18 apiece.\nMonte Rosa Therapeutics Inc. will join the Nasdaq Global Select Market as GLUE after selling shares at $19 each.\nConfluent Inc. will make its debut as CFLT. The company's shares were sold in the IPO for $36 each.\nMiromatrix Medical will make its debut on the Nasdaq as MIRO after selling shares at $9 each.\nGrove Inc. will trade as GRVI after selling its stock in the IPO at $5 apiece.","news_type":1},"isVote":1,"tweetType":1,"viewCount":223,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":167795333,"gmtCreate":1624284133722,"gmtModify":1703832446519,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"Just a passing storm!","listText":"Just a passing storm!","text":"Just a passing storm!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/167795333","repostId":"1171968125","repostType":4,"repost":{"id":"1171968125","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624282019,"share":"https://ttm.financial/m/news/1171968125?lang=&edition=fundamental","pubTime":"2021-06-21 21:26","market":"us","language":"en","title":"Dow jumps more than 200 points, rebounds from its worst week since October","url":"https://stock-news.laohu8.com/highlight/detail?id=1171968125","media":"Tiger Newspress","summary":"(June 21) U.S. stocks climbed on Monday as the market attempted to rebound from the Dow Jones Indust","content":"<p>(June 21)&nbsp;U.S. stocks climbed on Monday as the market attempted to rebound from the Dow Jones Industrial average's worst week since October.</p>\n<p>The blue-chip Dow rose 220 points, while the S&amp;P 500 gained 0.3%. The tech-heavy Nasdaq Composite traded near the flatline.</p>\n<p>Commodity stocks that were hit hard last week were rebounding, including Exxon and Chevron up about 1% apiece. Reopening plays including Royal Caribbean and Boeing were slightly higher. Banks including JPMorgan, Bank of America and Goldman Sachs also rebounded.</p>\n<p>U.S. stocks fell last week as investors digested new economic projections from the Federal Reserve and worried rate hikes could come sooner than expected. The Fed on Wednesdayraised its inflation expectations and forecast rate hikes in 2023. St. Louis Fed President Jim BullardsaidFriday on CNBC's&nbsp;\"Squawk Box\"that it was natural for the central bank to tilt a little more \"hawkish\" and saw higher interest rates as soon as 2022.</p>\n<p>\"The Fed's 'surprise' move toward tapering that took markets lower last week is just the moment of recognition for a tightening trend that began months ago,\" Mike Wilson, chief U.S. equity strategist, said in a note. \"When combined with the peak rate of change in economic and earnings revisions, it sets up a more difficult summer.\"</p>\n<p>The Dow dropped 3.5% last week, while the S&amp;P 500 and Nasdaq dipped 1.9% and 0.2%, respectively, on the week.</p>\n<p>The U.S. market on Monday was resilient in the face of an overnight drop in Asian markets and a big decline in bitcoin. Japan'sNikkei 225 fell as muchas 4% at one point on Monday with automakers Nissan and Honda leading the way. It would end up closing about 3% lower.</p>\n<p>Meanwhile, bitcoinfell more than 6% to $33,000as China continued its crackdown on cryptocurrency mining.</p>\n<p>Sectors tied to the economic recovery led last week's dip in stocks. The S&amp;P 500 financials and materials sectors lost more than 6% on the week, while energy fell more than 5% and industrials dropped more than 3%.</p>\n<p>Those sectors looked set to rebound Monday. The Financial Select Sector SPDR Fund was rebounding by 0.3% in premarket trading. The Materials Select Sector SPDR Fund was higher by 0.6%.</p>\n<p>The Treasury yield curve flattened last week, hitting banks and sending a signal of a potential economic slowdown. The yields of shorter-term Treasurys, like the 2-year note, rose — reflecting expectations of the Fed raising rates. Longer-term yields, like the 10-year note, retreated — a sign of less optimism toward economic growth.</p>\n<p>Investors await public appearances from Fed members on Monday. Bullard and Dallas Fed President Robert Kaplan are set to speak virtually on a Official Monetary and Financial Institutions Forum panel at 9:00 a.m. ET. New York Fed President John Williams is expected to deliver remarks at a Midsize Bank Coalition of America event Monday afternoon.</p>\n<p>Blockchain&nbsp;stocks&nbsp;fell.</p>\n<p><img src=\"https://static.tigerbbs.com/721381ed3fffc8fb65784c8662c2e5bd\" tg-width=\"312\" tg-height=\"325\" referrerpolicy=\"no-referrer\"></p>\n<p>Big&nbsp;tech&nbsp;stocks&nbsp;fell.</p>\n<p><img src=\"https://static.tigerbbs.com/414a6810bde91ea4d477f0a6190fbb08\" tg-width=\"308\" tg-height=\"323\" referrerpolicy=\"no-referrer\"></p>\n<p>Bank&nbsp;stocks&nbsp;rally.</p>\n<p><img src=\"https://static.tigerbbs.com/3d0aa47ccb01c822ed35519fa4aaf6b0\" tg-width=\"312\" tg-height=\"442\" referrerpolicy=\"no-referrer\"></p>\n<p></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow jumps more than 200 points, rebounds from its worst week since October</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow jumps more than 200 points, rebounds from its worst week since October\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-21 21:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(June 21)&nbsp;U.S. stocks climbed on Monday as the market attempted to rebound from the Dow Jones Industrial average's worst week since October.</p>\n<p>The blue-chip Dow rose 220 points, while the S&amp;P 500 gained 0.3%. The tech-heavy Nasdaq Composite traded near the flatline.</p>\n<p>Commodity stocks that were hit hard last week were rebounding, including Exxon and Chevron up about 1% apiece. Reopening plays including Royal Caribbean and Boeing were slightly higher. Banks including JPMorgan, Bank of America and Goldman Sachs also rebounded.</p>\n<p>U.S. stocks fell last week as investors digested new economic projections from the Federal Reserve and worried rate hikes could come sooner than expected. The Fed on Wednesdayraised its inflation expectations and forecast rate hikes in 2023. St. Louis Fed President Jim BullardsaidFriday on CNBC's&nbsp;\"Squawk Box\"that it was natural for the central bank to tilt a little more \"hawkish\" and saw higher interest rates as soon as 2022.</p>\n<p>\"The Fed's 'surprise' move toward tapering that took markets lower last week is just the moment of recognition for a tightening trend that began months ago,\" Mike Wilson, chief U.S. equity strategist, said in a note. \"When combined with the peak rate of change in economic and earnings revisions, it sets up a more difficult summer.\"</p>\n<p>The Dow dropped 3.5% last week, while the S&amp;P 500 and Nasdaq dipped 1.9% and 0.2%, respectively, on the week.</p>\n<p>The U.S. market on Monday was resilient in the face of an overnight drop in Asian markets and a big decline in bitcoin. Japan'sNikkei 225 fell as muchas 4% at one point on Monday with automakers Nissan and Honda leading the way. It would end up closing about 3% lower.</p>\n<p>Meanwhile, bitcoinfell more than 6% to $33,000as China continued its crackdown on cryptocurrency mining.</p>\n<p>Sectors tied to the economic recovery led last week's dip in stocks. The S&amp;P 500 financials and materials sectors lost more than 6% on the week, while energy fell more than 5% and industrials dropped more than 3%.</p>\n<p>Those sectors looked set to rebound Monday. The Financial Select Sector SPDR Fund was rebounding by 0.3% in premarket trading. The Materials Select Sector SPDR Fund was higher by 0.6%.</p>\n<p>The Treasury yield curve flattened last week, hitting banks and sending a signal of a potential economic slowdown. The yields of shorter-term Treasurys, like the 2-year note, rose — reflecting expectations of the Fed raising rates. Longer-term yields, like the 10-year note, retreated — a sign of less optimism toward economic growth.</p>\n<p>Investors await public appearances from Fed members on Monday. Bullard and Dallas Fed President Robert Kaplan are set to speak virtually on a Official Monetary and Financial Institutions Forum panel at 9:00 a.m. ET. New York Fed President John Williams is expected to deliver remarks at a Midsize Bank Coalition of America event Monday afternoon.</p>\n<p>Blockchain&nbsp;stocks&nbsp;fell.</p>\n<p><img src=\"https://static.tigerbbs.com/721381ed3fffc8fb65784c8662c2e5bd\" tg-width=\"312\" tg-height=\"325\" referrerpolicy=\"no-referrer\"></p>\n<p>Big&nbsp;tech&nbsp;stocks&nbsp;fell.</p>\n<p><img src=\"https://static.tigerbbs.com/414a6810bde91ea4d477f0a6190fbb08\" tg-width=\"308\" tg-height=\"323\" referrerpolicy=\"no-referrer\"></p>\n<p>Bank&nbsp;stocks&nbsp;rally.</p>\n<p><img src=\"https://static.tigerbbs.com/3d0aa47ccb01c822ed35519fa4aaf6b0\" tg-width=\"312\" tg-height=\"442\" referrerpolicy=\"no-referrer\"></p>\n<p></p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index","SPY":"标普500ETF",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171968125","content_text":"(June 21) U.S. stocks climbed on Monday as the market attempted to rebound from the Dow Jones Industrial average's worst week since October.\nThe blue-chip Dow rose 220 points, while the S&P 500 gained 0.3%. The tech-heavy Nasdaq Composite traded near the flatline.\nCommodity stocks that were hit hard last week were rebounding, including Exxon and Chevron up about 1% apiece. Reopening plays including Royal Caribbean and Boeing were slightly higher. Banks including JPMorgan, Bank of America and Goldman Sachs also rebounded.\nU.S. stocks fell last week as investors digested new economic projections from the Federal Reserve and worried rate hikes could come sooner than expected. The Fed on Wednesdayraised its inflation expectations and forecast rate hikes in 2023. St. Louis Fed President Jim BullardsaidFriday on CNBC's \"Squawk Box\"that it was natural for the central bank to tilt a little more \"hawkish\" and saw higher interest rates as soon as 2022.\n\"The Fed's 'surprise' move toward tapering that took markets lower last week is just the moment of recognition for a tightening trend that began months ago,\" Mike Wilson, chief U.S. equity strategist, said in a note. \"When combined with the peak rate of change in economic and earnings revisions, it sets up a more difficult summer.\"\nThe Dow dropped 3.5% last week, while the S&P 500 and Nasdaq dipped 1.9% and 0.2%, respectively, on the week.\nThe U.S. market on Monday was resilient in the face of an overnight drop in Asian markets and a big decline in bitcoin. Japan'sNikkei 225 fell as muchas 4% at one point on Monday with automakers Nissan and Honda leading the way. It would end up closing about 3% lower.\nMeanwhile, bitcoinfell more than 6% to $33,000as China continued its crackdown on cryptocurrency mining.\nSectors tied to the economic recovery led last week's dip in stocks. The S&P 500 financials and materials sectors lost more than 6% on the week, while energy fell more than 5% and industrials dropped more than 3%.\nThose sectors looked set to rebound Monday. The Financial Select Sector SPDR Fund was rebounding by 0.3% in premarket trading. The Materials Select Sector SPDR Fund was higher by 0.6%.\nThe Treasury yield curve flattened last week, hitting banks and sending a signal of a potential economic slowdown. The yields of shorter-term Treasurys, like the 2-year note, rose — reflecting expectations of the Fed raising rates. Longer-term yields, like the 10-year note, retreated — a sign of less optimism toward economic growth.\nInvestors await public appearances from Fed members on Monday. Bullard and Dallas Fed President Robert Kaplan are set to speak virtually on a Official Monetary and Financial Institutions Forum panel at 9:00 a.m. ET. New York Fed President John Williams is expected to deliver remarks at a Midsize Bank Coalition of America event Monday afternoon.\nBlockchain stocks fell.\n\nBig tech stocks fell.\n\nBank stocks rally.","news_type":1},"isVote":1,"tweetType":1,"viewCount":100,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":167796481,"gmtCreate":1624284096743,"gmtModify":1703832445030,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PYPL\">$PayPal(PYPL)$</a>To greater heights!","listText":"<a href=\"https://laohu8.com/S/PYPL\">$PayPal(PYPL)$</a>To greater heights!","text":"$PayPal(PYPL)$To greater heights!","images":[{"img":"https://static.tigerbbs.com/1a3ff9e9129413d22b7bcda883f77356","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/167796481","isVote":1,"tweetType":1,"viewCount":116,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":162939114,"gmtCreate":1624030518138,"gmtModify":1703827186550,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MTCH\">$Match(MTCH)$</a>up!","listText":"<a href=\"https://laohu8.com/S/MTCH\">$Match(MTCH)$</a>up!","text":"$Match(MTCH)$up!","images":[{"img":"https://static.tigerbbs.com/99cd573dea84efb2571133ca8ad0a986","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/162939114","isVote":1,"tweetType":1,"viewCount":47,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":131246060,"gmtCreate":1621864956850,"gmtModify":1704363521661,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IDXX\">$IDEXX Laboratories(IDXX)$</a>=)","listText":"<a href=\"https://laohu8.com/S/IDXX\">$IDEXX Laboratories(IDXX)$</a>=)","text":"$IDEXX Laboratories(IDXX)$=)","images":[{"img":"https://static.tigerbbs.com/02dea9d4fadad029b48718f4e0794171","width":"1125","height":"2183"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/131246060","isVote":1,"tweetType":1,"viewCount":122,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":156771898,"gmtCreate":1625238755214,"gmtModify":1703739253097,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/156771898","repostId":"1115261715","repostType":2,"repost":{"id":"1115261715","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1625125255,"share":"https://ttm.financial/m/news/1115261715?lang=&edition=fundamental","pubTime":"2021-07-01 15:40","market":"us","language":"en","title":"Look back to the first half of the year: U.S. stock indexs hit record high, these stocks are winner","url":"https://stock-news.laohu8.com/highlight/detail?id=1115261715","media":"Tiger Newspress","summary":"(July 1) The global market officially ended in the first half of the year. On the whole, the French ","content":"<p>(July&nbsp;1)&nbsp;The global market officially ended in the first half of the year. On the whole, the French CAC 40 index took the lead with an increase of 17.2%; the S&amp;P 500 index and the Eurozone Stoxx 50 index increased by 14.4% Tied for second place; followed by the Mexico Composite Index and the German DAX 30 Index, with gains of 14.1% and 13.2%, respectively.</p>\n<p><img src=\"https://static.tigerbbs.com/b0699623d049666a5b8b1af052f8e0d8\" tg-width=\"670\" tg-height=\"1408\" referrerpolicy=\"no-referrer\"></p>\n<p><b>U.S. stock indexes hit record high, energy stocks are winners</b></p>\n<p>U.S. stocks in the first half of the year generally showed a trend of volatility and upward movement. The three major indexes jointly set a new record high. The S&amp;P 500 index rose by 14.41% in the first half of the year, which has outperformed the index's average annual growth rate of 11% in the past two decades, and far outpaced the 4% increase in the first half of last year; the Nasdaq index rose by 12.54 % in the first half of the year, the Dow Jones index rose 12.73%.</p>\n<p>From the perspective of sectors and individual stocks, \"economic recovery\" and \"increasing inflation\" are the two main factors&nbsp;that dominated the U.S. stock market in the first half of the year. Under the influence of these two main factors, energy stocks, finance stocks and real estate stocks outperformed other sectors.</p>\n<p><img src=\"https://static.tigerbbs.com/4697acc988167e0c0adfe0713ce52b64\" tg-width=\"1924\" tg-height=\"1080\" referrerpolicy=\"no-referrer\"></p>\n<p>In the first half of this year, with the gradual promotion of the global vaccinations against the new crown, China took the lead in getting out of the shadow of the epidemic, and many European and American countries have gradually begun to loosen their blockades. With the recovery of global economy and the rebound in demand for commodities, especially the rapid rise in energy demand, Brent crude oil is the best performing asset in the first half of the year, with a yield of 44.32%.</p>\n<p>Benefiting from the explosion of demand, US energy stocks are also the top performers. Among the S&amp;P 500 constituent stocks, five of the top ten gainers are energy stocks. Among them, Marathon Petroleum ranked first with a half-year increase of 105.55%. The other four are Diamondback Energy, Devon Energy, Occidental Petroleum and EOG Energy, with increases of 96.07%, 91.64%, 80.77% and 69.30% respectively.</p>\n<p><img src=\"https://static.tigerbbs.com/bf9454f083cdbfc0296a0d9c53d53fe6\" tg-width=\"1924\" tg-height=\"1082\" referrerpolicy=\"no-referrer\"></p>\n<p>In addition, among the constituent stocks of the Dow, energy stocks are also among the top performers. Chevron ranked fourth with an increase of 27.32%, and Caterpillar ranked eighth with an increase of 20.74%. Among the constituent stocks of the Dow, the performance of bank stocks is also remarkable.</p>\n<p>Bank stocks performed very well during the epidemic, with the help of legislators and the Federal Reserve. Three of the top five companies in the Dow's gainers are bank stocks. Among them, Goldman Sachs ranked first with increaing 44.97%; American Express ranked second with a 37.55% increase, and JPMorgan Chase ranked fifth with a 24.01% increase.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Look back to the first half of the year: U.S. stock indexs hit record high, these stocks are winner</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLook back to the first half of the year: U.S. stock indexs hit record high, these stocks are winner\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-07-01 15:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(July&nbsp;1)&nbsp;The global market officially ended in the first half of the year. On the whole, the French CAC 40 index took the lead with an increase of 17.2%; the S&amp;P 500 index and the Eurozone Stoxx 50 index increased by 14.4% Tied for second place; followed by the Mexico Composite Index and the German DAX 30 Index, with gains of 14.1% and 13.2%, respectively.</p>\n<p><img src=\"https://static.tigerbbs.com/b0699623d049666a5b8b1af052f8e0d8\" tg-width=\"670\" tg-height=\"1408\" referrerpolicy=\"no-referrer\"></p>\n<p><b>U.S. stock indexes hit record high, energy stocks are winners</b></p>\n<p>U.S. stocks in the first half of the year generally showed a trend of volatility and upward movement. The three major indexes jointly set a new record high. The S&amp;P 500 index rose by 14.41% in the first half of the year, which has outperformed the index's average annual growth rate of 11% in the past two decades, and far outpaced the 4% increase in the first half of last year; the Nasdaq index rose by 12.54 % in the first half of the year, the Dow Jones index rose 12.73%.</p>\n<p>From the perspective of sectors and individual stocks, \"economic recovery\" and \"increasing inflation\" are the two main factors&nbsp;that dominated the U.S. stock market in the first half of the year. Under the influence of these two main factors, energy stocks, finance stocks and real estate stocks outperformed other sectors.</p>\n<p><img src=\"https://static.tigerbbs.com/4697acc988167e0c0adfe0713ce52b64\" tg-width=\"1924\" tg-height=\"1080\" referrerpolicy=\"no-referrer\"></p>\n<p>In the first half of this year, with the gradual promotion of the global vaccinations against the new crown, China took the lead in getting out of the shadow of the epidemic, and many European and American countries have gradually begun to loosen their blockades. With the recovery of global economy and the rebound in demand for commodities, especially the rapid rise in energy demand, Brent crude oil is the best performing asset in the first half of the year, with a yield of 44.32%.</p>\n<p>Benefiting from the explosion of demand, US energy stocks are also the top performers. Among the S&amp;P 500 constituent stocks, five of the top ten gainers are energy stocks. Among them, Marathon Petroleum ranked first with a half-year increase of 105.55%. The other four are Diamondback Energy, Devon Energy, Occidental Petroleum and EOG Energy, with increases of 96.07%, 91.64%, 80.77% and 69.30% respectively.</p>\n<p><img src=\"https://static.tigerbbs.com/bf9454f083cdbfc0296a0d9c53d53fe6\" tg-width=\"1924\" tg-height=\"1082\" referrerpolicy=\"no-referrer\"></p>\n<p>In addition, among the constituent stocks of the Dow, energy stocks are also among the top performers. Chevron ranked fourth with an increase of 27.32%, and Caterpillar ranked eighth with an increase of 20.74%. Among the constituent stocks of the Dow, the performance of bank stocks is also remarkable.</p>\n<p>Bank stocks performed very well during the epidemic, with the help of legislators and the Federal Reserve. Three of the top five companies in the Dow's gainers are bank stocks. Among them, Goldman Sachs ranked first with increaing 44.97%; American Express ranked second with a 37.55% increase, and JPMorgan Chase ranked fifth with a 24.01% increase.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite","SPY":"标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115261715","content_text":"(July 1) The global market officially ended in the first half of the year. On the whole, the French CAC 40 index took the lead with an increase of 17.2%; the S&P 500 index and the Eurozone Stoxx 50 index increased by 14.4% Tied for second place; followed by the Mexico Composite Index and the German DAX 30 Index, with gains of 14.1% and 13.2%, respectively.\n\nU.S. stock indexes hit record high, energy stocks are winners\nU.S. stocks in the first half of the year generally showed a trend of volatility and upward movement. The three major indexes jointly set a new record high. The S&P 500 index rose by 14.41% in the first half of the year, which has outperformed the index's average annual growth rate of 11% in the past two decades, and far outpaced the 4% increase in the first half of last year; the Nasdaq index rose by 12.54 % in the first half of the year, the Dow Jones index rose 12.73%.\nFrom the perspective of sectors and individual stocks, \"economic recovery\" and \"increasing inflation\" are the two main factors that dominated the U.S. stock market in the first half of the year. Under the influence of these two main factors, energy stocks, finance stocks and real estate stocks outperformed other sectors.\n\nIn the first half of this year, with the gradual promotion of the global vaccinations against the new crown, China took the lead in getting out of the shadow of the epidemic, and many European and American countries have gradually begun to loosen their blockades. With the recovery of global economy and the rebound in demand for commodities, especially the rapid rise in energy demand, Brent crude oil is the best performing asset in the first half of the year, with a yield of 44.32%.\nBenefiting from the explosion of demand, US energy stocks are also the top performers. Among the S&P 500 constituent stocks, five of the top ten gainers are energy stocks. Among them, Marathon Petroleum ranked first with a half-year increase of 105.55%. The other four are Diamondback Energy, Devon Energy, Occidental Petroleum and EOG Energy, with increases of 96.07%, 91.64%, 80.77% and 69.30% respectively.\n\nIn addition, among the constituent stocks of the Dow, energy stocks are also among the top performers. Chevron ranked fourth with an increase of 27.32%, and Caterpillar ranked eighth with an increase of 20.74%. Among the constituent stocks of the Dow, the performance of bank stocks is also remarkable.\nBank stocks performed very well during the epidemic, with the help of legislators and the Federal Reserve. Three of the top five companies in the Dow's gainers are bank stocks. Among them, Goldman Sachs ranked first with increaing 44.97%; American Express ranked second with a 37.55% increase, and JPMorgan Chase ranked fifth with a 24.01% increase.","news_type":1},"isVote":1,"tweetType":1,"viewCount":283,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":126731704,"gmtCreate":1624584113808,"gmtModify":1703840929351,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"Awesome!","listText":"Awesome!","text":"Awesome!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/126731704","repostId":"2145042230","repostType":4,"repost":{"id":"2145042230","kind":"news","pubTimestamp":1624578900,"share":"https://ttm.financial/m/news/2145042230?lang=&edition=fundamental","pubTime":"2021-06-25 07:55","market":"us","language":"en","title":"Eli Lilly Surges After Getting Breakthrough Therapy Designation From FDA, Analyst Raises PT and Sees Approval Chance at 90%, Biogen Plunges","url":"https://stock-news.laohu8.com/highlight/detail?id=2145042230","media":"StreetInsider","summary":"Shares of Eli Lilly and Company (NYSE: LLY) are up over 9% in today’s trading session after the comp","content":"<p>Shares of Eli Lilly and Company (NYSE: LLY) are up over 9% in today’s trading session after the company obtained the Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for donanemab, the company’s investigational antibody therapy for Alzheimer's disease (AD).</p>\n<p>This designation is granted to companies in a bid to accelerate the development and review of therapies meant to treat serious conditions when preliminary clinical results show that the relevant drug is ahead of already available therapies that have received full FDA approval.</p>\n<p>Donanemab is an investigational antibody treatment developed by Lilly’s that targets a modified form of beta-amyloid named N3pG. In its Phase 2 trial, the company studied the efficacy and safety of the drug in patients with early Alzheimer’s disease.</p>\n<p>Stifel analyst Paul Matteis says the designation has “multiple implications for the sector.” Shares of Biogen (NASDAQ: BIIB) are down over 5% on LLY news.</p>\n<p>“LLY's plans to file donanemab this morning for accelerated approval later this year is somewhat surprising to us from a timing perspective, not because of the efficacy data (good enough relative to Adu), but because we were unsure whether the FDA would be comfortable with the size of the safety dataset. This has multiple implications for BIIB (incrementally negative) and the abeta space,” the analyst said in a note.</p>\n<p>“On the <a href=\"https://laohu8.com/S/AONE\">one</a> hand, it increases competition for BIIB: LLY's actual clinical data are less confusing, and Biogen is mired in a string of bad press regarding pricing; competition could drive down the net price. Meanwhile, it also may impact the multiple that investors put in anti-amyloid agent revenues in general. Biogen has 9 years to complete its confirmatory trial; however, LLY's second donanemab study is ongoing and may readout considerably sooner, and may set up as a relevant catalyst, positive or negative, for the plight of both drugs.”</p>\n<p>Mizuho analyst Vamil Divan raised the price target on the Buy-rated LLY to $250.00 per share from $216.00 per share as “it is difficult to argue why donanemab would NOT be approved, given the speed and depth of plaque clearance donanemab demonstrated in TRAILBLAZER-ALZ and prior studies.”</p>\n<p>“We increase our probability of donanemab's regulatory approval to 90% (from 60%), assuming an accelerated approval will be based on amyloid plaque clearance, something donanemab has already consistently demonstrated. We also move up our donanemab launch to the start of 2023 (from 2024), but acknowledge this could even prove to still be a little conservative. However, we note that BIIB has guided to only “modest” revenues this year after its June 7 approval, so would assume fairly limited donanemab sales in 2022 even if Lilly gets an approval in the middle of the year. On the other hand, Lilly may be able to leverage some of what BIIB is doing now to secure coverage and access for anti-amyloid therapies, allowing for potentially more rapid market uptake. Lilly would also have the potential advantage of having confirmatory clinical data much sooner than BIIB, given their TRAILBLAZER-ALZ 2 trial is ongoing, with recruitment expected to be completed by year-end and full data expected by mid-2023,” Divan writes in a report on LLY.</p>\n<p>“We now estimate donanemab probability-adjusted sales of ~$11Bn in 2030, with room for further upside given the size of the Alzheimer's market. Our donanemab estimate changes drive our Lilly price target to $250 (from $217), with room for upside on a faster approval, a higher price (we currently assume $30K net per patient per year in the US and $15K in the EU and Japan), more rapid market uptake and/or higher peak sales. Our price target based on a 75%/25% blend of discounted cash flow (DCF) valuation at $259 and relative valuation at $222. Our DCF is based on cash flows forecasted through 2030, along with a 6.5% discount rate and a 0.5% rate of terminal growth. Our relative valuation is based on a 30.0x multiple of 2021 P/E using our estimate of Lilly’s 2021 EPS.”</p>\n<p>Lilly plans to apply for the biologics license (BLA) for donanemab under the expedited approval pathway later in 2021 based on data from Phase 2. The safety and efficacy of the drug are also being assessed in the ongoing Phase 3 study.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Surges After Getting Breakthrough Therapy Designation From FDA, Analyst Raises PT and Sees Approval Chance at 90%, Biogen Plunges</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Surges After Getting Breakthrough Therapy Designation From FDA, Analyst Raises PT and Sees Approval Chance at 90%, Biogen Plunges\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 07:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18600310><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Eli Lilly and Company (NYSE: LLY) are up over 9% in today’s trading session after the company obtained the Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18600310\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司","LLY":"礼来"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18600310","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2145042230","content_text":"Shares of Eli Lilly and Company (NYSE: LLY) are up over 9% in today’s trading session after the company obtained the Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for donanemab, the company’s investigational antibody therapy for Alzheimer's disease (AD).\nThis designation is granted to companies in a bid to accelerate the development and review of therapies meant to treat serious conditions when preliminary clinical results show that the relevant drug is ahead of already available therapies that have received full FDA approval.\nDonanemab is an investigational antibody treatment developed by Lilly’s that targets a modified form of beta-amyloid named N3pG. In its Phase 2 trial, the company studied the efficacy and safety of the drug in patients with early Alzheimer’s disease.\nStifel analyst Paul Matteis says the designation has “multiple implications for the sector.” Shares of Biogen (NASDAQ: BIIB) are down over 5% on LLY news.\n“LLY's plans to file donanemab this morning for accelerated approval later this year is somewhat surprising to us from a timing perspective, not because of the efficacy data (good enough relative to Adu), but because we were unsure whether the FDA would be comfortable with the size of the safety dataset. This has multiple implications for BIIB (incrementally negative) and the abeta space,” the analyst said in a note.\n“On the one hand, it increases competition for BIIB: LLY's actual clinical data are less confusing, and Biogen is mired in a string of bad press regarding pricing; competition could drive down the net price. Meanwhile, it also may impact the multiple that investors put in anti-amyloid agent revenues in general. Biogen has 9 years to complete its confirmatory trial; however, LLY's second donanemab study is ongoing and may readout considerably sooner, and may set up as a relevant catalyst, positive or negative, for the plight of both drugs.”\nMizuho analyst Vamil Divan raised the price target on the Buy-rated LLY to $250.00 per share from $216.00 per share as “it is difficult to argue why donanemab would NOT be approved, given the speed and depth of plaque clearance donanemab demonstrated in TRAILBLAZER-ALZ and prior studies.”\n“We increase our probability of donanemab's regulatory approval to 90% (from 60%), assuming an accelerated approval will be based on amyloid plaque clearance, something donanemab has already consistently demonstrated. We also move up our donanemab launch to the start of 2023 (from 2024), but acknowledge this could even prove to still be a little conservative. However, we note that BIIB has guided to only “modest” revenues this year after its June 7 approval, so would assume fairly limited donanemab sales in 2022 even if Lilly gets an approval in the middle of the year. On the other hand, Lilly may be able to leverage some of what BIIB is doing now to secure coverage and access for anti-amyloid therapies, allowing for potentially more rapid market uptake. Lilly would also have the potential advantage of having confirmatory clinical data much sooner than BIIB, given their TRAILBLAZER-ALZ 2 trial is ongoing, with recruitment expected to be completed by year-end and full data expected by mid-2023,” Divan writes in a report on LLY.\n“We now estimate donanemab probability-adjusted sales of ~$11Bn in 2030, with room for further upside given the size of the Alzheimer's market. Our donanemab estimate changes drive our Lilly price target to $250 (from $217), with room for upside on a faster approval, a higher price (we currently assume $30K net per patient per year in the US and $15K in the EU and Japan), more rapid market uptake and/or higher peak sales. Our price target based on a 75%/25% blend of discounted cash flow (DCF) valuation at $259 and relative valuation at $222. Our DCF is based on cash flows forecasted through 2030, along with a 6.5% discount rate and a 0.5% rate of terminal growth. Our relative valuation is based on a 30.0x multiple of 2021 P/E using our estimate of Lilly’s 2021 EPS.”\nLilly plans to apply for the biologics license (BLA) for donanemab under the expedited approval pathway later in 2021 based on data from Phase 2. The safety and efficacy of the drug are also being assessed in the ongoing Phase 3 study.","news_type":1},"isVote":1,"tweetType":1,"viewCount":109,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":126491661,"gmtCreate":1624580840353,"gmtModify":1703840771095,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"[Surprised]&nbsp;","listText":"[Surprised]&nbsp;","text":"[Surprised]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/126491661","repostId":"1151333793","repostType":4,"repost":{"id":"1151333793","kind":"news","pubTimestamp":1624578319,"share":"https://ttm.financial/m/news/1151333793?lang=&edition=fundamental","pubTime":"2021-06-25 07:45","market":"us","language":"en","title":"Nike forecast for online sales boom, post-lockdown demand drives shares up 13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1151333793","media":"Reuters","summary":"(Reuters) -Nike Inc on Thursday forecast fiscal full-year sales ahead of Wall Street estimates, bett","content":"<p>(Reuters) -Nike Inc on Thursday forecast fiscal full-year sales ahead of Wall Street estimates, betting on its online business, higher demand as lockdowns ease, and its tried-and-tested strategy of limiting stock for popular products.</p>\n<p>The sneaker maker’s shares rose nearly 13% after the bell as the company also posted better-than-expected quarterly earnings and revenue.</p>\n<p>After staying at home for more than a year and limiting themselves to leisure-wear and comfortable pajamas, consumers are back to buying sneakers for running and hiking as they return to their routines, thanks to rapid vaccinations.</p>\n<p>There were definite reasons for optimism and confidence, like the return to sport, Chief Financial Officer Matthew Friend said on an earnings call, adding that Nike has already begun to see an acceleration in its sport performance business.</p>\n<p>Beaverton, Oregon-based Nike said fiscal 2022 revenue is estimated to grow by low double-digits and surpass $50 billion. Analysts had expected revenue of $48.46 billion for fiscal 2022, according to Refinitiv.</p>\n<p>First-half growth is expected to be slightly higher than second half growth, Friend said.</p>\n<p>In Nike’s biggest market, North America, fourth-quarter revenue more than doubled to $5.38 billion and beat the average analysts’ estimate of $4.31 billion.</p>\n<p>Total gross margin rose 8.5 percentage points to 45.8% versus last year, boosted in part by the company’s direct to consumer business and fewer charges related to factory cancellations. Analysts expected gross margin of 43.96%, according to Refinitiv.</p>\n<p>Net income came in at $1.51 billion, or 93 cents per share, for the quarter ended May 31, compared with a loss of $790 million, or 51 cents per share, a year earlier.</p>\n<p>Total revenue nearly doubled to $12.34 billion from a year ago, when the pandemic was at its peak. Analysts were expecting revenue of $11.01 billion and earnings of 51 cents per share, according to IBES data from Refinitiv.</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nike forecast for online sales boom, post-lockdown demand drives shares up 13%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNike forecast for online sales boom, post-lockdown demand drives shares up 13%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 07:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/article/nike-results/update-3-nike-forecast-for-online-sales-boom-post-lockdown-demand-drives-shares-up-13-idUSL3N2O63ZI><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) -Nike Inc on Thursday forecast fiscal full-year sales ahead of Wall Street estimates, betting on its online business, higher demand as lockdowns ease, and its tried-and-tested strategy of ...</p>\n\n<a href=\"https://www.reuters.com/article/nike-results/update-3-nike-forecast-for-online-sales-boom-post-lockdown-demand-drives-shares-up-13-idUSL3N2O63ZI\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NKE":"耐克"},"source_url":"https://www.reuters.com/article/nike-results/update-3-nike-forecast-for-online-sales-boom-post-lockdown-demand-drives-shares-up-13-idUSL3N2O63ZI","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151333793","content_text":"(Reuters) -Nike Inc on Thursday forecast fiscal full-year sales ahead of Wall Street estimates, betting on its online business, higher demand as lockdowns ease, and its tried-and-tested strategy of limiting stock for popular products.\nThe sneaker maker’s shares rose nearly 13% after the bell as the company also posted better-than-expected quarterly earnings and revenue.\nAfter staying at home for more than a year and limiting themselves to leisure-wear and comfortable pajamas, consumers are back to buying sneakers for running and hiking as they return to their routines, thanks to rapid vaccinations.\nThere were definite reasons for optimism and confidence, like the return to sport, Chief Financial Officer Matthew Friend said on an earnings call, adding that Nike has already begun to see an acceleration in its sport performance business.\nBeaverton, Oregon-based Nike said fiscal 2022 revenue is estimated to grow by low double-digits and surpass $50 billion. Analysts had expected revenue of $48.46 billion for fiscal 2022, according to Refinitiv.\nFirst-half growth is expected to be slightly higher than second half growth, Friend said.\nIn Nike’s biggest market, North America, fourth-quarter revenue more than doubled to $5.38 billion and beat the average analysts’ estimate of $4.31 billion.\nTotal gross margin rose 8.5 percentage points to 45.8% versus last year, boosted in part by the company’s direct to consumer business and fewer charges related to factory cancellations. Analysts expected gross margin of 43.96%, according to Refinitiv.\nNet income came in at $1.51 billion, or 93 cents per share, for the quarter ended May 31, compared with a loss of $790 million, or 51 cents per share, a year earlier.\nTotal revenue nearly doubled to $12.34 billion from a year ago, when the pandemic was at its peak. Analysts were expecting revenue of $11.01 billion and earnings of 51 cents per share, according to IBES data from Refinitiv.","news_type":1},"isVote":1,"tweetType":1,"viewCount":293,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":128593921,"gmtCreate":1624522332963,"gmtModify":1703839213688,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/V\">$Visa(V)$</a>[Miser]&nbsp;","listText":"<a href=\"https://laohu8.com/S/V\">$Visa(V)$</a>[Miser]&nbsp;","text":"$Visa(V)$[Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/128593921","isVote":1,"tweetType":1,"viewCount":369,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129441822,"gmtCreate":1624383833766,"gmtModify":1703835213613,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"Good day for S&amp;P","listText":"Good day for S&amp;P","text":"Good day for S&P","images":[{"img":"https://static.tigerbbs.com/e23d2dc900bb1fd5478aa91677df3d3c","width":"1125","height":"3461"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129441822","isVote":1,"tweetType":1,"viewCount":382,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":129443804,"gmtCreate":1624383693508,"gmtModify":1703835212472,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>[Surprised]&nbsp;[Surprised]&nbsp;[Surprised]&nbsp;","listText":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>[Surprised]&nbsp;[Surprised]&nbsp;[Surprised]&nbsp;","text":"$Moderna, Inc.(MRNA)$[Surprised] [Surprised] [Surprised]","images":[{"img":"https://static.tigerbbs.com/91ae1ea94b340ec39e5a395c2a145af3","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129443804","isVote":1,"tweetType":1,"viewCount":148,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":167445740,"gmtCreate":1624283377880,"gmtModify":1703832404464,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"To greater heights! [Miser]&nbsp;","listText":"To greater heights! [Miser]&nbsp;","text":"To greater heights! [Miser]","images":[{"img":"https://static.tigerbbs.com/f05b2957592e34ac0a60afae3b707932","width":"1125","height":"3372"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/167445740","isVote":1,"tweetType":1,"viewCount":258,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":169417744,"gmtCreate":1623847289288,"gmtModify":1703821226035,"author":{"id":"3575669786186618","authorId":"3575669786186618","name":"Adrian89","avatar":"https://static.tigerbbs.com/36b4b75806fbfc44154d0cc81727c284","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575669786186618","authorIdStr":"3575669786186618"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RBLX\">$Roblox Corporation(RBLX)$</a>=(=(=(","listText":"<a href=\"https://laohu8.com/S/RBLX\">$Roblox Corporation(RBLX)$</a>=(=(=(","text":"$Roblox Corporation(RBLX)$=(=(=(","images":[{"img":"https://static.tigerbbs.com/a4d1b1e12e5caed6244a1570207ae59e","width":"1125","height":"2183"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/169417744","isVote":1,"tweetType":1,"viewCount":226,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}